Posts by fang:

NIO公司公佈2024年11月交付數據 “`

2024年11月交付量為20,575輛, 同比增長28.9%2024年累計交付量為190,832輛,同比增長34.4%截至2024年11月30日,累計交付量達到640,426輛   (SeaPRwire) -   上海,2024年12月1日 -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO)(“NIO”或“公司”),全球智能電動汽車市場的先驅和領先公司,今日宣佈其2024年11月交付結果。 公司2024年11月交付汽車20,575輛,同比增長28.9%。交付量包括公司高端智能電動汽車品牌NIO的15,493輛和公司面向家庭的智能電動汽車品牌ONVO的5,082輛。截至2024年11月30日,累計交付量達到640,426輛。 2024年11月25日是NIO的十週年紀念日。在過去十年中,NIO在產品設計、技術創新和重新構思的商業模式方面不斷突破界限。憑藉其全棧自主研發的技術能力、覆蓋全國的龐大電力網絡和獨特的用戶社區,NIO已為未來發展奠定了堅實基礎。展望未來,NIO始終致力於創造可持續發展和更美好的未來。公司將繼續通過持續的技術突破和創新、卓越的產品和服務以及共享增長的社區為用戶創造價值。 關於NIO Inc. NIO Inc.是全球智能電動汽車市場的先驅和領先公司。NIO成立於2014年11月,其使命是“藍天將至”,致力於創造可持續發展和更美好的未來。NIO將自己定位為一家用戶企業,將創新技術與卓越體驗相結合。NIO設計、開發、製造和銷售智能電動汽車,推動下一代核心技術的創新。NIO通過持續的技術突破和創新、卓越的產品和服務以及共享增長的社區來區別於其他公司。NIO旗下擁有NIO品牌的高端智能電動汽車,以及ONVO品牌的家庭導向型智能電動汽車。 安全港聲明 本新聞稿包含根據1995年美國《私人證券訴訟改革法案》的“安全港”條款可能構成“前瞻性”聲明的陳述。這些前瞻性陳述可通過諸如“將”、“預期”、“預計”、“目標”、“未來”、“打算”、“計劃”、“相信”、“估計”、“可能”等術語以及類似陳述來識別。NIO也可能在其提交給美國證券交易委員會(“SEC”)的定期報告、其給股東的年度報告、在其網站、香港聯合交易所有限公司(“SEHK”)和新加坡交易所證券交易有限公司(“SGX-ST”)網站上發佈的公告、通函或其他出版物、新聞稿和其他書面材料以及其管理人員、董事或僱員對第三方的口頭陳述中發表書面或口頭前瞻性陳述。非歷史事實的陳述,包括關於NIO的信念、計劃和預期的陳述,都是前瞻性陳述。前瞻性陳述包含固有的風險和不確定性。許多因素可能導致實際結果與任何前瞻性陳述中包含的結果存在重大差異,包括但不限於:NIO的策略;NIO未來的業務發展、財務狀況和經營成果;NIO按計劃和規模生產具有足夠質量和吸引力的汽車的能力;其確保和擴大生產能力(包括與第三方建立和維持合作夥伴關係)的能力;其為客戶提供便捷和全面的電力解決方案的能力;電池交換、BaaS和NIO輔助和智能駕駛及其訂閱服務的可行性、增長潛力以及前景;其改進技術或開發替代技術以滿足不斷變化的市場需求和行業發展的能力;NIO滿足與機動車相關的法定安全標準的能力;其確保其車輛使用的原材料或其他組件供應的能力;其確保其車輛足夠預訂量和銷量的能力;其控制與其運營相關的成本的能力;其建立其當前和未來品牌的能力;全球和中國的普遍經濟和商業狀況以及與上述任何一項相關或與其相關的假設。關於這些和其他風險的更多信息包含在NIO提交給SEC的文件以及SEHK和SGX-ST網站上的公告和文件中。本新聞稿中提供的所有信息均截至本新聞稿發佈之日,NIO不承擔更新任何前瞻性陳述的義務,除非適用法律要求。 更多信息,請訪問:http://ir.nio.com 投資者關係ir@nio.com 媒體關係global.press@nio.com本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

小鵬汽車公佈2024年11月汽車交付數據

11月交付量達30,895輛,同比增長54%MONA M03連續三個月交付量超過10,000輛P7+的推出推動了強勁的交付勢頭 (SeaPRwire) -   中國廣州,2024年12月1日 -- 小鵬汽車(「小鵬」或「公司」,紐約證券交易所:XPEV 和香港交易所:9868),一家領先的中國智能電動汽車(「智能電動汽車」)公司,今天宣佈了2024年11月創紀錄的汽車交付結果。 小鵬汽車在2024年11月交付了30,895輛智能電動汽車,同比增長54%,環比增長29%。自推出以來,小鵬MONA M03的交付量連續三個月超過10,000輛。小鵬P7+上市23天後,交付量已超過7,000輛。2024年前11個月,小鵬汽車交付了153,373輛智能電動汽車,同比增長26%。 11月,XNGP在城市駕駛中的月活躍用戶滲透率達到85%。2024年11月15日,廣州車展開幕當天,小鵬成功完成行業首個基於統一軟件套件的「門到門」ADAS測試,在停車場、高速公路和城市道路上提供一致的體驗。 此外,11月,小鵬汽車正式進軍尼泊爾和英國市場。同時,小鵬的旗艦車型G6在國際市場上也日益受到關注。在備受矚目的2024年丹麥年度汽車頒獎典禮上,小鵬G6榮獲了令人垂涎的2024年度科技先鋒獎。 關於小鵬汽車 小鵬汽車是一家領先的中國智能電動汽車公司,設計、開發、製造和銷售吸引廣大且不斷增長的技術savvy中產階級消費者的智能電動汽車。其使命是通過技術推動智能電動汽車的轉型,塑造未來出行體驗。為了優化客戶的出行體驗,小鵬汽車自主開發了全棧式先進駕駛輔助系統技術和車載智能操作系統,以及包括動力總成和電氣/電子架構在內的核心汽車系統。小鵬汽車總部位於中國廣州,在北京、上海、硅谷、聖地牙哥和阿姆斯特丹設有主要辦公室。小鵬汽車的智能電動汽車主要在其位於廣東省肇慶和廣州的工廠生產。更多信息,請訪問。 安全港聲明 本公告包含前瞻性陳述。這些陳述是根據1995年美國私人證券訴訟改革法案的「安全港」條款作出的。這些前瞻性陳述可以用諸如「將」、「預期」、「預計」、「未來」、「打算」、「計劃」、「相信」、「估計」和類似陳述等術語來識別。非歷史事實的陳述,包括關於小鵬汽車的信念和預期的陳述,都是前瞻性陳述。前瞻性陳述包含固有的風險和不確定性。許多因素可能導致實際結果與任何前瞻性陳述中包含的結果存在重大差異,包括但不限於:小鵬汽車的目標和戰略;小鵬汽車的擴張計劃;小鵬汽車未來的業務發展、財務狀況和經營成果;中國電動汽車市場的趨勢和規模;小鵬汽車對其產品和服務的需求和市場接受度的預期;小鵬汽車對其與客戶、合同製造商、供應商、第三方服務提供商、戰略合作夥伴和其他利益相關者關係的預期;一般的經濟和商業狀況;以及與上述任何一項相關的或與之相關的假設。關於這些和其他風險的更多信息包含在小鵬汽車提交給美國證券交易委員會的文件中。本新聞稿中提供的所有信息均截至本新聞稿發佈之日,除適用法律要求外,小鵬汽車不承擔更新任何前瞻性陳述的義務。 聯繫方式: 投資者查詢: 投資者關係部門小鵬汽車電郵:  蔡珍妮Piacente Financial Communications電話:+1 212 481 2050 / +86 10 6508 0677電郵:  媒體查詢: 公關部門小鵬汽車電郵:  來源:小鵬汽車本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

理想汽車股份有限公司 2024 年 11 月交付更新 “`

(SeaPRwire) -   北京,中國,2024年12月1日 -- 位於中國新能源汽車市場領先地位的理想汽車股份有限公司(「理想汽車」或「公司」)(納斯達克股票代碼:LI;香港交易所股票代碼:2015)今日宣佈,其2024年11月交付量為48,740輛,同比增長18.8%。截至2024年11月30日,理想汽車2024年累計交付量為441,995輛,累計交付量達到1,075,359輛。 理想汽車連續八個月保持中國品牌20萬元以上乘用車市場銷量冠軍。理想L6累計交付量突破16萬輛,自6月份以來一直保持中國品牌20萬元以上車型銷量冠軍。此外,公司在自動駕駛技術上的持續進展提升了搭載理想AD Max車型的需求。11月份,搭載理想AD Max的車型在30萬元以上和40萬元以上車型的訂單中分別佔比超過70%和80%。公司於11月發佈了OTA更新版本6.5,為所有理想AD Max用戶提供了一鍵式點對點自動駕駛功能,充分利用其端到端(E2E)和視覺語言模型(VLM)技術。 截至2024年11月30日,公司在141個城市擁有475家零售店,在223個城市擁有451家服務中心和理想汽車授權的鈑噴中心,以及1,135個配備5,680個充電樁的超級充電站。 關於理想汽車股份有限公司 理想汽車股份有限公司是中國新能源汽車市場的領先者。公司設計、研發、製造和銷售高端智能電動汽車。其使命是:創造移動的家,創造幸福的家。通過在產品、技術和商業模式上的創新,公司為家庭提供安全、便捷、舒適的產品和服務。理想汽車是成功將增程式電動汽車商業化應用於中國的先驅。在堅定推進這一技術路線的同時,公司也在並行建設純電動汽車平台。公司利用技術為用戶創造價值。其內部研發工作主要集中在自主研發的增程系統、創新的電動汽車技術和智能汽車解決方案上。公司於2019年11月開始量產。其目前的產品線包括理想MEGA,一款高科技旗艦家庭MPV;理想L9,一款六座旗艦家庭SUV;理想L8,一款六座高端家庭SUV;理想L7,一款五座旗艦家庭SUV;以及理想L6,一款五座高端家庭SUV。公司將繼續擴大其產品線,以面向更廣泛的用戶群體。 更多信息,請訪問:https://ir.lixiang.com。 安全港聲明 本新聞稿包含根據1995年美國私人證券訴訟改革法案的「安全港」條款可能構成「前瞻性」聲明的陳述。這些前瞻性陳述可以通過諸如「將」、「預期」、「預計」、「目標」、「未來」、「打算」、「計劃」、「相信」、「估計」、「目標」、「可能」、「挑戰」以及類似陳述等術語來識別。理想汽車也可能在其提交給美國證券交易委員會(「SEC」)和香港聯合交易所有限公司(「HKEX」)的定期報告中,在其年度股東報告中,在其新聞稿和其他書面材料中,以及由其管理人員、董事或僱員向第三方作出的口頭陳述中作出書面或口頭的前瞻性陳述。非歷史事實的陳述,包括關於理想汽車的信念、計劃和預期的陳述,都是前瞻性陳述。前瞻性陳述涉及固有的風險和不確定性。許多因素可能導致實際結果與任何前瞻性陳述中包含的結果存在重大差異,包括但不限於:理想汽車的策略、未來的業務發展以及財務狀況和經營成果;理想汽車有限的經營歷史;與增程式電動汽車和高功率充電純電動汽車相關的風險;理想汽車開發、製造和交付高品質和受客戶歡迎的汽車的能力;理想汽車產生正現金流和利潤的能力;產品缺陷或任何其他車輛未能按預期運行的故障;理想汽車成功競爭的能力;理想汽車建立其品牌和抵禦負面宣傳的能力;理想汽車車輛訂單的取消;理想汽車開發新車輛的能力;以及消費者需求和政府激勵措施、補貼或其他有利的政府政策的變化。關於這些和其他風險的更多信息包含在理想汽車向SEC和HKEX提交的文件中。本新聞稿中提供的所有信息均截至本新聞稿發佈之日,理想汽車不承擔更新任何前瞻性聲明的義務,除非適用法律要求。 投資者和媒體查詢,請聯繫: 理想汽車股份有限公司投資者關係電郵:ir@lixiang.com Christensen AdvisoryRoger Hu電話:+86-10-5900-1548電郵:Li@christensencomms.com本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Military Metals Issues Invitation to Tender for Resource Estimation at Its Trojarova Antimony-Gold Property in Slovakia

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - November 25, 2024) - Military Metals Corp. (CSE:MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") has issued an invitation to tender bids for carrying out a mineral resource estimation at the Company's Trojarová antimony-gold property in Slovakia. Three companies with recognized technical credentials were selected to submit bids.Trojarová, located in the heart of Europe, had prior development and production operations in respect of antimony. Historical resource estimates were produced in connection with Soviet era work conducted on the property, in accordance with the Russian classification system at the time. Please refer to the Company's news release dated October 30, 2024 for more detailed information about this antimony-gold deposit and the prior estimates. The historical work conducted is instructive as to future work programs to be conducted by the Company.The Company expects to receive bids by December 20, 2024 and to make a decision by year's end as to which company it will commission with a three-fold task:Input all historical data into a digital data base, including drill logs and analyses, plans, section, underground geological mapping and sampling, historical block modeling and all other relevant data, in order to generate an independent three-dimensional model and seek to verify the accuracy of the historical estimates on the property:Make recommendations to management in regard to the number, location, orientation and depth of twin and infill holes to be drilled, along with all quality assurance, quality control protocols, in order that the non-compliant historical resource can be upgraded and classified as a mineral resource in accordance with current industry standards;On completion of the new drill program outlined in items 1 and 2 above, input all newly generated drill data and prepare a "maiden" mineral resource estimate.Management eagerly awaits receipt of bids and then plans to move forward with the above three step program. With continuation of high antimony prices and demand, management believes that conducting work on Trojarová can add significant value for shareholders.The technical contents of this release were reviewed and approved by Avrom E. Howard, MSc, PGeo, geological consultant to Military Metals and a qualified person as defined by NI 43-101.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes statements related to the filing of a NI 43-101 compliant technical report, activities related to the classification of mineralization documented at Trojarova as a current mineral resource, work to be conducted by the successful bidding party for the work described in the news release, future drill programs and other exploration work, and any future plans for activities at Trojarova. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, future prices of antimony, availability of capital and labour in respect of Trojarova, any required approvals related to exploration activities to be conducted, the completion of successful bids as part of the process outlined in the news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact any future activities in respect of the properties held by the Company. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231241 Copyright 2024 ACN Newswire via SeaPRwire.com.

Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC).The SENSITIZE study was initiated by Professor Juliana Chan, an international endocrinology specialist at The Chinese University of Hong Kong, as the lead researcher. It is the first clinical study in Asian populations to evaluate the impact of GKA on β-cell glucose sensitivity in the populations with varying degrees of impaired glucose tolerance using the technology of hyperglycemic clamp. The study aims to explore the impairment of glucokinase (GK) function and clinical characteristics in different types of glucose dysregulation, providing new scientific evidence on the pathophysiology of Asian Type 2 diabetes and the central role of GK in blood glucose regulation.The SENSITIZE 2 study results announced at CBIIC demonstrate that a single dose of dorzagliatin restores GK enzyme activity, significantly improving the second-phase insulin secretion and β-cell glucose sensitivity in individuals with impaired glucose tolerance (IGT) in hyperglycemic clamp study. In addition, the SENSITIZE 1 study previously reported at the 2022 ADA annual meeting showed that dorzagliatin directly restores the activity of GK mutants, leading to significant improvements in the second-phase insulin secretion and β-cell glucose sensitivity in patients with glucokinase monogenic diabetes (GCK-MODY or MODY-2), and significantly enhance basal insulin secretion in newly diagnosed type 2 diabetes patients.Hua Medicine will continue to investigate β-cell glucose sensitivity improvement and incretin effect in response of repeated dose of dorzagliatin in individuals with intermediate hyperglycemia (IH) and Type 2 diabetes, in order to establish personalized intervention and treatment management plans for prediabetic and Type 2 diabetes patients.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

Nasdaq 上市規則除牌及重新符合規定通知 “`

(SeaPRwire) -   香港,2024年11月30日 -- 2024年11月21日,普瑞美加集團控股有限公司 (納斯達克股票代碼:PGHL)(「公司」)收到納斯達克證券市場有限公司(「納斯達克」)上市資格部門的通知,指公司未支付根據納斯達克上市規則 5900 系列(「退市通知」)規定應付的若干費用。納斯達克上市規則 5250(f) 規定,「公司必須支付規則 5900 系列中所述的所有適用費用。」納斯達克通知公司,未能遵守此規定是將公司證券從納斯達克資本市場退市的依據。納斯達克的通知進一步說明,如果公司不選擇提出上訴,公司將面臨從納斯達克資本市場退市,而公司的股份將於2024年12月3日停牌。 公司已於2024年11月26日全額償還未付費用。2024年11月27日,公司收到納斯達克的通知,表示在履行某些披露義務(本新聞稿是其中一部分)的條件下,有關未付費用的事項已結案。 公司現已符合納斯達克上市規則 5250(f) 的規定。 公司股份的交易不受影響,並照常進行。 退市通知不會影響公司的業務營運或財務狀況,我們仍然專注於保持業務增長。公司及其任何子公司均未受到納斯達克的任何進一步紀律處分。 PRIMEGA GROUP HOLDINGS LIMITED 關於 Primega Group Holdings Limited Primega Group Holdings Limited 是一家提供運輸服務的公司,採用環保措施,旨在促進建築和拆除材料的再利用及減少建築廢料。公司透過在香港的營運子公司,在建築業營運,主要負責處理從建築工地挖掘出來的材料的運輸。服務主要包括:(i) 土石運輸服務;(ii) 柴油貿易;及 (iii) 建築工程,主要包括挖掘及側向支撐工程及鑽孔灌注樁工程。公司一般以分包商身份向香港其他建築承包商提供服務。 前瞻性陳述 本新聞稿中的某些陳述屬於前瞻性陳述。這些前瞻性陳述涉及已知和未知的風險和不確定性,並基於公司目前對可能影響其財務狀況、營運成果、業務策略和財務需求的未來事件的預期和預測。投資者可以通過使用諸如「近似」、「相信」、「希望」、「預期」、「預計」、「估計」、「預測」、「打算」、「計劃」、「將」、「會」、「應該」、「可能」或本新聞稿中其他類似表達方式來找到許多(但不是全部)這些陳述。除非法律要求,否則公司沒有義務公開更新或修改任何前瞻性陳述以反映隨後發生的事件或情況,或其預期的變化。雖然公司相信這些前瞻性陳述中表達的預期是合理的,但它不能向您保證這些預期將被證明是正確的,並且公司告誡投資者,實際結果可能與預期結果存在重大差異,並鼓勵投資者審閱可能影響其未來結果的其他因素在公司提交給美國證券交易委員會的文件中。 有關投資者和媒體查詢,請聯絡: 公司資料Primega Group Holdings Limited董事長 Man Siu Mingmsm@primegagroup.com+852 3997 3682 投資者關係HBK Strategy LimitedKaty Chan, Directorir@hbkstrategy.com+852 2498 3681本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

限時黑色星期五優惠:iFLYTEK 智能翻譯機享 20% 折扣

(SeaPRwire) -   中國合肥,2024年11月29日 -- 作為人工智能領域公認的創新者和先進語言技術的倡導者,科大訊飛(iFLYTEK)正為無縫的多語種溝通樹立標準。今年黑色星期五,科大訊飛(iFLYTEK)為其旗艦產品提供獨家20% 的折扣,這是一款尖端的設備,擁有離線功能,並可實時進行面對面翻譯,支援60種語言。這款不可或缺的工具原價為399.99美元,現在只需319.99美元即可購買。這個限時優惠為您提供了獲得可靠且專業級翻譯工具的絕佳機會。 為什麼選擇科大訊飛(iFLYTEK)智能翻譯器? 科大訊飛(iFLYTEK)智能翻譯器是一款先進的多功能工具,旨在讓全球溝通變得輕鬆自如。無論您是追蹤新聞的記者、在全球商務中運作的專業人士,還是處理關鍵調查的警官,智能翻譯器都能為您提供高效、安全地完成工作的技術支持。最近,科大訊飛(iFLYTEK)智能翻譯器被Geeky Gadgets列入「黑色星期五高性能高科技必需品促銷」清單,進一步鞏固了其作為專業人士不可或缺工具的聲譽。 主要功能: 卓越的翻譯準確性:科大訊飛(iFLYTEK)智能翻譯器由科大訊飛(iFLYTEK)專有的AI引擎提供支持,可提供高達98% 的行業領先的翻譯準確性。它能夠熟練地處理複雜的短語、慣用語和細微的文化差異,確保對話的意義和真實性。全球首款離線語音轉文字記錄器 - 讓每個字都至關重要:想像一下,捕捉口語內容並立即將其轉換為文字,而無需依賴互聯網連接。此功能使您能夠實時記錄重要的對話、採訪或會議,即使在連接有限的地方也能做到。對於記者和警官來說,這確保了關鍵信息永遠不會丟失。支持60種語言和方言:該設備支持63種語言(包括地區方言)的語音和文本翻譯。無論是在歐洲、亞洲還是非洲,用戶都可以自信地應對語言環境,並以當地人的母語與他們交流。高效的轉錄 - 節省時間,更聰明地工作:時間寶貴,尤其是在截止日期臨近時。智能翻譯器的快速轉錄功能讓您幾乎可以立即獲得準確的結果。快節奏環境中的專業人士現在可以專注於分析和決策,而不是費力地進行人工記錄。實時溝通,實現自然對話:翻譯器的實時功能可實現輕鬆的面對面互動。它具有即時、同步級別的翻譯功能,確保流暢和動態的溝通,而不會出現尷尬的停頓。智能降噪技術 - 聽到重要的內容,忽略其餘內容:繁忙的街道、擁擠的新聞發佈室或嘈雜的辦公室對此設備來說都不是挑戰。其先進的降噪麥克風可以過濾掉背景聲音,讓您專注於重要的詞語。這確保了記者即使在混亂的環境中也能獲得清晰的錄音,專業人士也能在喧囂的環境中有效地進行溝通。圖像翻譯,適用於視覺情境:該設備整合了先進的光學字符識別 (OCR) 技術,可以翻譯50多種語言的圖片文本。用戶只需拍攝標誌、菜單、文檔或包裝的圖片,即可獲得即時翻譯,從而提高旅行和專業環境中的便利性和可用性。緊湊、輕便的設計,長續航電池:該設備重量僅為180克,採用符合人體工程學的設計,便於攜帶和使用。它還配備了長續航電池,可支持長達10小時的持續使用,確保在長時間旅行或會議期間的可靠性。 多種翻譯模式支持: 對話模式:促進不同語言使用者之間的互動式對話。廣播模式:將單個說話者的話翻譯成多種語言的聽眾,非常適合演示或群組設置。同步模式:為不間斷的溝通提供實時字幕式翻譯。 科大訊飛(iFLYTEK)智能翻譯器的黑色星期五獨家優惠 該產品將先進的AI技術與實用功能相結合,以滿足全球用戶的多樣化需求。無論是探索國際目的地的旅行者、從事跨境業務的專業人士、學習外語的學生,還是管理多語種互動的個人,這款設備都能提供高效可靠的解決方案。 今年黑色星期五,科大訊飛(iFLYTEK)智能翻譯器被Geeky Gadgets在其「黑色星期五高性能高科技必需品促銷」清單中重點推薦,突出了其在各個專業領域的價值。它現在以20% 的超值折扣出售,價格從399.99美元降至319.99美元! 抓住這個限時優惠的機會,以超值的價格擁有一款頂級翻譯設備。憑藉黑色星期五的折扣,現在是提升您的多語種溝通能力的最佳時機。立即訪問  ,在促銷結束前確保獲得您的科大訊飛(iFLYTEK)智能翻譯器。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 聯絡人:Jack Zheng iFLYTEK CO.LTD. jkzheng at xiflytek.com

GrowMatic 宣佈推出績效型 SEO 服務 “`

(SeaPRwire) -   新加坡,2024年11月29日 -- GrowMatic 是一家專門設計能帶來真正可量化成果的個性化搜尋引擎優化 (SEO) 策略的公司,很高興宣布推出其新的績效導向 SEO 服務。這項新服務為企業提供了一種有效的方法,讓代理商根據可衡量的有機收入增長獲得報酬。 績效導向 SEO 是一種以收入為導向的服務模式,它將付款直接與可衡量的有機增長結果聯繫起來。與傳統的固定費用安排不同,像 GrowMatic 這樣的代理商可以獲得超過既定基準的有機收入增長百分比。這種方法通過仔細追蹤收入、技術優化和持續績效衡量,創造了真正的夥伴關係,將代理商的成功直接與客戶的成果聯繫起來。 GrowMatic 的專業績效導向 SEO 非常適合尋求可靠方式實現可持續增長的成熟電子商務商店、Shopify 商店和 SaaS 公司。這家頂尖的 SEO 公司採用四項支柱方法,將技術卓越、內容優化、權威性建設和轉化優化相結合,以提供可衡量的投資回報率和顯著的有機收入增長。 公司發言人表示:「在 GrowMatic,我們專門為成熟企業實施數據驅動的解決方案,收取超過初始基準的有機收入增長百分比。」「這種模式消除了前期風險,同時確保代理商和客戶的成功通過共同的責任和以收入為中心的優化策略相一致。」 GrowMatic 提供的績效導向 SEO 流程包括五個策略階段,這些階段通過高級分析和持續衡量將 SEO 活動直接與收入增長聯繫起來。每個階段都基於詳細的績效數據來制定和執行策略,以產生可衡量的有機收入增長,從而決定公司的績效導向費用。具體如下: 1. 績效基準評估 績效基準評估通過分析 12 個月的歷史數據,建立衡量未來收入增長的精確指標。這項全面的評估為績效導向定價模式奠定了基礎,並確定了最有價值的增長機會,例如有機流量趨勢、關鍵字排名、轉化率、技術 SEO 狀態、競爭對手績效和收入歸因。 2. 客製化策略開發 客製化策略開發根據收入潛力和基準績效數據制定有針對性的行動計劃。GrowMatic 分析企業的特定商業模式、市場地位和增長目標,以制定專注於最快實現有機收入增長的策略。 3. 實施和優化 實施和優化通過系統化的網站改進和內容增強來執行戰略重點。SEO 專家專注於能產生最高收入影響的更改,同時保持嚴格的質量標準,例如高價值內容優化、關鍵技術修復、戰略內部鏈接、促進收入的內容創作、有針對性的鏈接建設和增強的 Schema 標記。 4. 收入影響追蹤 使用高級歸因模型,收入影響追蹤衡量 SEO 改進與有機收入增長之間的直接相關性。這種精確的追蹤確定了績效導向費用,並證明了明確的投資回報率 (ROI)。 5. 持續增長優化 持續增長優化根據實時績效數據調整策略,以最大限度地提高收入增長。GrowMatic 分析每周指標、策略有效性評分、競爭地位監控和每月績效分析,以確定最有效的策略並調整其方法以放大成功的模式。 除了 GrowMatic 的績效導向 SEO 服務外,公司還提供一系列領先的 SEO 和公共關係服務。這些包括: SEO 諮詢:從戰略方向到為內部 SEO 團隊和代理商提供技術解決方案指導,使用高級方法改進其 SEO 運營和結果,SEO 專家提供專業見解、驗證策略並分享促進有機增長的成熟方法。 新聞稿分發:GrowMatic 的新聞稿分發服務使企業能夠在其新聞發佈到 750 多個信譽良好的新聞網站上。它包括從專業寫作到廣泛分發的一切,確保每個公告的能見度最大化。 客製化 SEO 服務:GrowMatic 的客製化 SEO 服務經過精心設計,旨在提供能帶來真正可量化成果的個性化 SEO 策略。這些包括 Synthetic Search Generation™,它能產生真正的品牌搜索信號,通過高質量的反向鏈接利用戰略權威性建設,並利用本地引用來提升本地知名度。 GrowMatic 憑藉其對通過績效導向策略交付切實可衡量成果的承諾,因其尖端的 SEO 技術和數據驅動的見解而贏得了令人印象深刻的聲譽,這些見解使企業能夠取得可見的成果和可持續的增長。 GrowMatic 鼓勵企業今天訪問其網站,進一步了解其績效導向 SEO 服務以及如何通過系統改進搜索可見性、流量質量和轉化率來提高其收入增長。 關於 GrowMatic GrowMatic 是一家專業的 SEO 代理商,通過績效導向的策略提供切實可衡量的成果。通過利用尖端技術和數據驅動的見解,GrowMatic 為電子商務、SaaS 和各種其他企業打造個性化的 SEO 解決方案,確保提高排名、實現可持續增長和增加有機收入。 更多信息 要了解有關 GrowMatic 及其績效導向 SEO 服務推出的更多信息,請訪問 。 來源: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 聯絡方式:GrowMatic 1 North Bridge Rd, #B1-35 High Street Center #B1-35 High Street Center 179094 新加坡 +1-830-225-2834 https://growmatic.io/

Horizon 與 SOLOWIN 合作,提供增強的 OMS 和演算法解決方案

(SeaPRwire) -   香港,2024年11月29日 -- SOLOWIN HOLDINGS (Nasdaq: SWIN)(「SOLOWIN」或「公司」),一家領先的金融服務公司,為高淨值和機構投資者提供傳統和虛擬資產的解決方案,今天宣布與Horizon Trading Solutions(「Horizon」)建立戰略合作夥伴關係。Horizon是全球電子交易解決方案和資本市場算法技術的領導者,將Horizon的尖端算法技術和訂單管理系統(「OMS」)整合到Solomon JFZ的機構級股票交易系統以及最近推出的現貨虛擬資產ETF中。 Horizon的優質託管及託管服務模式提供全天候的跟隨太陽支持,確保客戶持續獲得協助。Horizon已大力投資先進的共同託管基礎設施,方便在香港交易所快速執行訂單,並提供實時延遲監控。此外,Horizon的定制倉位管理和賣空模組使高頻機構交易公司能夠通過FIX協議無縫提交訂單,從而顯著提高其交易效率。 香港是全球首個支持創新實物申購和贖回現貨虛擬資產ETF的市場。Solomon JFZ作為其持續致力於連接傳統金融(TradFi)和去中心化金融(DeFi)的一部分,為機構投資者提供跨資產市場准入和優質執行服務。 作為中國資產管理公司和豐收環球投資管理的虛擬資產現貨ETF的主要參與經紀商之一,Solomon JFZ已成為香港各種現貨虛擬資產ETF中最大的客戶資產持有者。 SOLOWIN首席執行官Thomas Tam評論道:「Horizon是全球領先的電子交易解決方案和算法技術提供商之一,以其值得信賴的地位和在設計全面的機構OMS和基於算法的解決方案方面的豐富經驗而聞名。與這樣一家可靠的技術服務提供商合作,無疑將增強交易執行、提高效率並提高客戶的適應性,尤其對於新加入的機構交易客戶。」 Horizon Trading Solutions亞太及中東非地區主管Emmanuel Faure補充道:「我們很高興能與SOLOWIN合作,將先進的OMS和算法解決方案帶到亞洲虛擬資產交易的前沿。隨著市場從傳統資產向數字資產轉型,此次合作突顯了Horizon對創新和高性能交易技術的承諾。」 關於Horizon Trading Solutions Horizon Trading Solutions是一家獨立的全球科技公司,專注於電子交易,支持股票、衍生品和虛擬資產領域的代理和自營業務。20多年來,我們一直為全球領先的資本市場參與者提供尖端的算法技術和直接交易所連接。我們的多資產平台和對客戶成功的深切承諾使我們能夠提供簡化的性能:讓交易更容易成功。更多信息,請瀏覽公司網站:. 關於Solowin Holdings Solowin Holdings (NASDAQ: SWIN)是一家位於香港的金融服務公司,為全球高淨值和機構投資者提供全面的“一站式”解決方案。Solowin的業務涵蓋傳統和虛擬資產,其產品和服務包括投資銀行、財富管理、資產管理和Web3,旨在支持下一代投資者。Solowin的全資子公司Solomon JFZ (Asia) Holdings Limited(「Solomon JFZ」)是香港首批獲得監管的虛擬資產服務提供商之一。其先進的電子平台Solomon VA+是香港首個整合傳統和虛擬資產交易以及財富管理服務的多合一應用程式。 更多信息,請瀏覽公司網站: 或投資者關係網站:。 前瞻性陳述 本公告中的某些聲明是前瞻性聲明。這些前瞻性聲明涉及已知和未知的風險和不確定性,並基於公司目前對可能影響公司財務狀況、經營成果、業務戰略和財務需求的未來事件的預期和預測。投資者可以通過「可能」、「將」、「預期」、「預計」、「目標」、「估計」、「打算」、「計劃」、「相信」、「可能」、「潛在」、「繼續」或其他類似表達來識別這些前瞻性聲明。除非法律要求,否則公司沒有義務公開更新或修改任何前瞻性聲明以反映此後發生的事件或情況,或公司在此日期之後產生的預期變化。這些聲明受不確定性和風險的影響,包括但不限於與市場狀況相關的不確定性和公司最近提交的20-F表年度報告「風險因素」部分以及不時向證券交易委員會提交或提供的其他報告中討論的其他因素。儘管公司相信這些前瞻性聲明中表達的預期是合理的,但公司不能向您保證這些預期將被證明是正確的,並且公司告誡投資者實際結果可能與預期結果存在重大差異,並鼓勵投資者審閱可能影響公司未來結果的其他因素,這些因素可在公司的證券交易委員會檔案中找到,可在查閱。 垂詢投資者及媒體,請聯繫: SOLOWIN HOLDINGS 投資者關係部門電郵: Ascent Investor Relations LLCTina Xiao電話:+1-646-932-7242電郵: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate

SHANGHAI, Nov 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC).The Phase Ia clinical trial of the second-generation GKA (HM-002-1005) was conducted in the United States in 40 subjects with Type 2 diabetes (T2D). This trial was randomized, double-blind, placebo-controlled, single-dose, focusing on safety, tolerability, and pharmacokinetics. The second-generation GKA is a novel molecular entity with optimized physicochemical properties, holding new patents, and serving as the prodrug of dorzagliatin (HMS5552). This study designed for once-daily oral administration. Its aim is to extend the drug's action duration in the body through sustained-release technology, enhance patient compliance, and prolong the stimulation of GLP-1 secretion in the intestines.The Single Ascending Dose (SAD) study demonstrates that HM-002-1005 tablets can be rapidly converted to HMS5552 in the human body, with minimal exposure level of prodrug in both blood and urine. The t1/2 (biological half-life) after a single dose of HM-002-1005 tablets was prolonged compared to dorzagliatin tablets. The Cmax of HMS5552 in plasma after a 184.5mg single dose is comparable to the plasma concentration of HMS5552 after a 75mg single dose of dorzagliatin tablet; likewise, the daily AUC of HMS5552 in plasma after a single dose of HM-002-1005 tablets is comparable to the exposure level of HMS5552 after a 75mg BID dose of dorzagliatin tablets. The research indicates that HM-002-1005 tablets are near-completely converted to HMS5552 in human, and its pharmacokinetic characteristics support for once-daily oral administration. The development of HM-002-1005 tablets not only contributes to enhancing patient medication adherence and effectively control blood glucose levels within 24 hours; meanwhile, it also offers the opportunity to explore the Maximum Tolerated Dose above 150mg daily to achieve better efficacy. The 75 mg BID dose regiment was developed under the concept of Minimum Therapeutic Effective Dose in Chinese T2D patients who suffered from an impairment of insulin secretion and significant reduction of early phase insulin. The different disease characters of T2D with obesity in western patient population would benefit dorzagliatin from its effects on GLP-1 secretion and improvement of insulin sensitivity.With the confirmation that the exposure level of HM-002-1005 tablets at 184.5mg is comparable to dorzagliatin tablets at 75mg (BID), we will further optimize the dosage form followed by a Multiple Ascending Dose (MAD) clinical development of the 2nd generation GKA in China and the United States.Dr. Li CHEN, founder and CEO of Hua Medicine, stated, “Hua Medicine has always been committed to treating Type 2 diabetes at its root cause by restoring patients’ ability to autonomously regulate blood glucose levels. Over the course of a decade, the Company has selected dosing and clinical research protocols that are safe and effective for the majority of Chinese diabetes patients, leading to the successful development of GKA and the clinical application of dorzagliatin. Building on this foundation, the Company will undergo a strategic upgrade by further exploring the therapeutic potential of GKA, enriching its product pipeline and seeking partners both domestically and internationally, in order to benefit a broader range of patients, expand into global markets, and effectively establish the brand identity of GKA medications while maximizing the commercial potential of our global first-in-class drugs.”About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (Dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.

The Hong Kong Institute of Directors Announces Winners

HONG KONG, Nov 29, 2024 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Institute of Directors ("HKIoD") announced the winners of its Award Series for Director Excellence (the "Awards") – comprising the long-established Directors of the Year Awards ("DYA") and the inaugural Climate Governance Awards ("CGA"), at its Annual Dinner yesterday at the Hong Kong Convention and Exhibition Centre.  The event began with an opening speech by Dr Christopher To, Chairman of the HKIoD. Dr The Hon Moses Cheng Mo Chi, Non-official Member of the Executive Council of HKSARG, Mr Xu Wei Gang, Director General, Department of Economic Affairs, Liaison Office of the Central People's Government in HKSAR, Ms Salina Yan, JP, Permanent Secretary for Financial Services and the Treasury (Financial Services), and Dr Kelvin Wong, Chairman, Securities and Futures Commission ("SFC") and Chairman, Accounting and Financial Reporting Council ("AFRC") were invited as guests of honour. The response to the Awards submissions was overwhelmingly positive. After a lively discussion among the judges, this year's 19 winners, including directors and boards, were selected - all embodying the theme "Leading with Agility in an Era of Innovation". The awardees have demonstrated not only agility, but also the vision, courage and wisdom to lead against the backdrop of a demanding economic environment and prevailing geopolitical tensions. Moreover, they highlight the importance of having directors who can guide their companies in identifying the risks and opportunities associated with climate change, which are vital for ensuring the sustainability of the world and humanity.The Awardees of HKIoD Award Series* for Director Excellence 2024 are listed below:*Two series of Awards:- "DYA", acronym for "Directors Of The Year Awards"- "CGA", acronym for "Climate Governance Awards"In alphabetical order of names within categoryListed Companies CategoriesExecutive DirectorsDYAMr Chan Wai MingTown Ray Holdings LimitedCGAMs Clara Chan Yuen-shanLee Kee Holdings LimitedDYAMr Fu FanChina Pacific Insurance (Group) Co., LtdCGA Mr Li Wai LeungHengan Internationals Group Company LimitedMr Peter Wong Wai-YeeThe Hong Kong and China Gas Company LimitedDYA & CGAMr Yan Jianguo JPChina Overseas Land & Investment LimitedNon-Executive DirectorsDYA Dr Chung Shui Ming TimpsonChina Railway Group LimitedDr Tseng Shieng-chang CarterTCL Electronics Holdings LimitedProf Wang YijiangTCL Electronics Holdings LimitedBoardsDYA & CGAChina Resources Beer (Holdings) Company LimitedCGAHong Kong and China Gas Company LimitedDYA & CGAPing An Insurance (Group)Company of China, LtdCGAUnited Company RUSAL, international public joint-stock companyNon-listed Companies CategoriesExecutive DirectorsDYAMs Michelle ChanAS Watson IndustriesCGA Ir Prof Daniel M.ChengDunwell Technology (Holdings) Limited) (Dunwell Group)Ir Dr Cheng Sai Yau, VincentArup Fellow and Director of Climate and Sustainability in East AsiaDYAMr Orr Ka-yeung KevinWinner Medical (Hong Kong) LtdStatutory/ Non-profit-distributing Organisations CategoriesBoardsDYAHong Kong Tourism Board*In addition: recognition of Excellence in Board DiversityThe Institute of Internal Auditors Hong Kong*In addition: recognition of Excellence in Board DiversityThe guests of honour, special guests and officials to join the group photos together with the awardees (2nd row).About "HKIoD Award Series for Director Excellence"The HKIoD Award Series for Director Excellence is a project organised by The Hong Kong Institute of Directors ("HKIoD") and consists of two series of Awards.The first series, Directors Of The Year Awards, was inaugurated in 2001 as the first ever such Awards organised in Asia. As directors are ultimately responsible for corporate governance and leading the company in prosperity and integrity, the objectives of the Awards are to recognise outstanding boards and directors and to promote good practices in corporate governance and director professionalism. The Awards have become an annual project of impact in the community organised by HKIoD together with over 100 Project Partners. To date, 255 Awardees have been recognised for their achievements in demonstrating exemplary high standards in corporate governance and director practice.Inaugurated in 2024, Climate Governance Awards constitute the second series of HKIoD Awards with the objectives to recognise and inspire exemplary achievements in climate governance and to advocate climate action by directors. There are 10 awardees who have been acknowledged in the inaugural edition of the awards. It is critical time now for directors to address the risks and opportunities of climate change in board agendas and their governance role.Candidates are open to public nomination, with data processed in well-defined and stringent procedures, followed by interviews with independent consultants in utmost due diligence and finally selected by independent judges with high standards and fair judgment.  Awards are presented by company categories, viz Listed Companies, Non-listed Companies and Statutory/Non-profit-distributing Organisations, and by capacities, viz Executive Directors, Non-Executive Directors and Boards.About The Hong Kong Institute of Directors ("HKIoD")The Hong Kong Institute of Directors ("HKIoD") is Hong Kong's premier body representing directors working together to advance corporate sustainability in creating long-term value for companies, their owners, stakeholders, humankind and Planet Earth through advocacy and standards-setting in corporate governance and director professionalism. Led by Founder Chairman Dr The Hon Moses Cheng, HKIoD was founded in 1997. Throughout the years, HKIoD is honoured to have the Chief Executive of HKSAR as the Institute's Patron. Membership of HKIoD comprises of directors from diverse industries and corporate types and includes Executive Directors, Non-Executive Directors and Independent Non-Executive Directors.  With multi-culturalism and international perspectives, HKIoD organises activities that cover director training, seminars and forums, collective director voice, guideline establishment, public education, Award Series for Director Excellence, assessment of Corporate Governance Scorecard for listed companies etc.As a member body of the Global Network of Director Institutes ("GNDI"), HKIoD is committed to global collaboration in promoting good corporate governance and director professionalism. HKIoD is the appointed Host of the Hong Kong Chapter of Climate Governance Initiative, a global network that collaborates with the World Economic Forum in actively promoting directors' address of the risks and opportunities of climate change.For details please visit:http://www.hkiod.com|http://www.gndi.org|https://climate-governance.org/Media Enquiries:Award Series for Director Excellence:Strategic Public Relations Group LimitedThe Hong Kong Institute of DirectorsBrenda Chan+852 2114 4396/ brenda.chan@sprg.com.hkOdessa So +852 2889 4988/ odessa.so@hkiod.com Copyright 2024 ACN Newswire via SeaPRwire.com.

BitFuFu將參與首屆B. Riley證券能源融合會議

(SeaPRwire) -   新加坡,2024年11月29日 -- BitFuFu, Inc. (NASDAQ: FUFU, FUFU.WS)(「BitFuFu」或「公司」),一家全球領先的比特幣挖礦和綜合挖礦服務提供商,今日宣佈將參與首屆B. Riley Securities 能源融合會議:礦業、核能和基礎設施,該會議將於2024年12月4日星期三在紐約市的Hotel Eventi舉行。 BitFuFu的投資者關係副總裁Charley Brady將參與此次會議,並與機構投資者會面,討論BitFuFu 2024年第三季度的財務業績、最近收購埃塞俄比亞一座80兆瓦的礦場,以及其更長遠的戰略計劃。感興趣的投資者應聯繫他們的B. Riley銷售代表以註冊參加會議。 關於能源融合會議 B. Riley Securities 能源融合會議:礦業、核能和基礎設施,是一個僅限受邀參加的獨家活動,展出礦業、核能和基礎設施垂直領域的精選中小型上市公司,包括金融科技、可持續能源和技術以及金屬和礦業公司。該活動由B. Riley Securities 股票研究團隊主辦,將提供一個全面的時間表,包括由研究人員主持的小組討論、由分析師主持的圓桌會議、一對一會議和小組會議。 如有任何問題或疑慮,請隨時聯繫。 關於BitFuFu Inc. BitFuFu Inc. 是一家全球領先的比特幣挖礦和綜合挖礦服務提供商,為客戶提供一站式解決方案,例如雲挖礦。BitFuFu獲得了世界領先的數字資產挖礦硬件製造商BITMAIN的早期投資,並且仍然是BITMAIN在雲挖礦領域唯一的戰略合作夥伴。 BitFuFu致力於培養安全、合規和透明的區塊鏈基礎設施,為全球客戶群提供各種穩定和智能的數字資產挖礦解決方案。憑藉其不斷擴大的全球礦場網絡和與BITMAIN的戰略合作夥伴關係,BitFuFu使機構客戶和數字資產愛好者能夠高效地開採數字資產。 更多信息,請訪問。 前瞻性聲明 本新聞稿包含1995年美國私人證券訴訟改革法案「安全港」條款意義上的「前瞻性聲明」。前瞻性聲明可以使用諸如「估計」、「計劃」、「項目」、「預測」、「打算」、「將」、「預期」、「預計」、「相信」、「尋求」、「目標」或其他類似表達方式來識別,這些表達方式預測或指示未來的事件或趨勢。非歷史事實的陳述,包括關於公司信念和預期的陳述,都是前瞻性聲明。這些聲明基於各種假設(無論是否在本新聞稿中列明)以及BitFuFu管理層目前的預期,而不是對實際業績的預測。這些聲明涉及風險、不確定性和其他因素,這些因素可能導致BitFuFu的實際結果、活動水平、業績或成就與這些前瞻性聲明中明示或暗示的結果、活動水平、業績或成就存在重大差異。儘管公司相信其對本新聞稿中包含的每個前瞻性聲明都有合理的依據,但公司提醒您,這些聲明是基於目前已知的事實和因素以及對未來的預測的結合,而這些預測本身就是不確定的。本新聞稿中提供的所有信息均截至本新聞稿發佈之日,除非適用法律規定,否則公司不承擔更新此類信息的任何義務。 關於投資者和媒體查詢,請聯繫: BitFuFu 投資者關係  Charley Brady投資者關係副總裁 BitFuFu媒體關係本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

KANZHUN LIMITED將於2024年12月11日公佈2024年第三季度業績

(SeaPRwire) -   北京,2024年11月29日 -- KANZHUN LIMITED(“BOSS直聘”或“公司”)(Nasdaq: BZ; HKEX: 2076),中國領先的在線招聘平台,今日宣佈將於美國市場開盤前,在2024年12月11日(星期三)公佈截至2024年9月30日的第三季度未經審計合併財報。 公司將於2024年12月11日(星期三)北京時間晚上8:00(美國東部時間上午7:00)舉行電話會議,討論財報。 參與者需要預先註冊電話會議: 註冊後,參與者將收到一封包含參與者撥入號碼和唯一個人PIN碼的電子郵件。此信息將讓您立即加入電話會議。參與者可以隨時預先註冊,包括在電話會議開始時間之前和之後。 電話會議的現場和錄播網絡直播將在公司的投資者關係網站上提供:。 關於KANZHUN LIMITED KANZHUN LIMITED 在中國營運領先的在線招聘平台BOSS直聘。公司通過其高度互動的移動應用程式,以高效且無縫的方式連接求職者和企業用戶,該應用程式是一款變革性產品,它促進雙向溝通,專注於智能推薦,並在線上招聘過程中創造新的場景。得益於其龐大而多元化的用戶群體,BOSS直聘已發展出强大的網絡效應,從而提升招聘效率並推動快速發展。 更多信息,請瀏覽:。 投資者及媒體查詢,請聯繫: KANZHUN LIMITED投資者關係電郵: 在中国: PIACENTE FINANCIAL COMMUNICATIONSHelen Wu電話:+86-10-6508-0677電郵: 在美国: PIACENTE FINANCIAL COMMUNICATIONSBrandi Piacente電話:+1-212-481-2050電郵: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

iFlux Global 推出代幣分期付款:更聰明的加密貨幣投資方式

(SeaPRwire) -   新加坡,2024年11月28日 -- iFlux Global欣然宣布其代幣分期付款服務將於2024年12月5日正式推出。這個創新的金融產品在成功完成測試階段後,推出了非動態定價——這項改變遊戲規則的功能會根據實時市場數據,每天08:00(UTC)更新代幣價格,並將價格固定一整天。通過提供穩定的價格,iFlux幫助投資者避免情緒化買賣的風險,並使他們能夠獲得最佳的市場收益。 代幣分期付款服務適用於各種加密貨幣投資者。經驗豐富的交易者將欣賞其為多元化投資組合帶來的靈活性和成本效益。業餘交易者往往會受到衝動決策和有限資金的影響,現在可以專注於更聰明、更長期的策略。對於加密貨幣投資新手來說,代幣分期付款提供了一種輕鬆便捷的方式來參與數字經濟。 此服務允許投資者支付低至15%或高達85%的首付款來購買加密貨幣,具體取決於他們的財務策略,剩餘金額將分攤到可自定義的分期付款計劃中,時間範圍從10天到12個月不等。投資者受益於固定的每日利率,這確保了其合同期限內的價格穩定性。此外,即使在市場劇烈波動期間,也不存在保證金清算的風險。通過取消交易費用並允許無限制的資金提取,iFlux 提供了一種簡化且經濟高效的加密貨幣持有方法。 與傳統平台上代幣價格持續波動不同,iFlux 的每日價格鎖定機制使投資者能夠在沒有突然損失風險的情況下做出戰略決策。此功能鼓勵長期思考,並有助於避免常見的陷阱,例如 FOMO 驅動的購買或恐慌性拋售。 憑藉代幣分期付款服務,iFlux Global 正在重新定義人們參與加密貨幣投資的方式,確保每位投資者,無論其背景如何,都能夠自信地參與數字經濟。 iFlux Global 誠邀經驗豐富的投資者和新手投資者探索代幣分期付款服務的好處。通過專注於穩定性、透明度和靈活性,iFlux 為加密貨幣投資樹立了新標準。 如需了解更多關於代幣分期付款服務的資訊,請立即訪問 ,開始您的加密貨幣投資之旅。 關於 iFlux GlobaliFlux Global 是一個加密貨幣金融平台,致力於為全球交易者和投資者提供便捷、創新的解決方案。iFlux 專注於透明度、成本效益和用戶賦權,正在改變人們參與數字資產的方式。 網站和社交媒體: 網站:Twitter:Telegram:白皮書: 媒體聯繫:姓名:Sophie Austin職位:關係經理電子郵件:本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

NEFECON(R) Included in National Reimbursement Drug List (NRDL)

HONG KONG, Nov 29, 2024 - (ACN Newswire via SeaPRwire.com) - On November 28, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security announced the "National Reimbursement Drug List (2024)" (NRDL), which will officially take effect on January 1, 2025. NEFECON(R), the first etiological treatment for IgA nephropathy developed by Everest Medicines, was successfully included in the NRDL. This milestone signifies a breakthrough in advancing the standardization of IgAN treatment and improving accessibility and affordability, offering hope for millions of IgAN patients in China. NEFECON(R) has been prescribed in mainland China since May this year and has been approved in Macau, Hong Kong, Taiwan, China, South Korea and in Singapore under the trade name Nefegan(R).NEFECON(R) is the first ever treatment for IgAN to receive full approval from the U.S. Food and Drug Administration (FDA) and the first non-oncology therapeutic to receive breakthrough therapy designation in China by the China National Medical Products Administration (NMPA), underscoring its globally leading position and exceptional clinical value. Recently, at the 2024 American Society of Nephrology (ASN) Annual Meeting, data from the open-label extension (OLE) phase of the NefIgArd Phase 3 trial demonstrated that patients undergoing a second course of NEFECON(R) treatment experienced similar benefits in estimated glomerular filtration rate (eGFR) preservation and proteinuria reduction as observed after the initial treatment, with good tolerance. These findings further validate the feasibility and efficacy of long-term treatment strategies, aligning with recommendations from the "KDIGO 2024 Clinical Practice Guideline for The Management Of Immunoglobulin A Nephropathy (IgAN) And Immunoglobulin A Vasculitis (IgAV)", highlighting NEFECON(R)'s innovation and clinical value in IgAN treatment. NEFECON(R) was also listed as the only treatment proven to reduce the levels of pathogenic forms of IgA and IgA immune complexes.IgAN is highly prevalent in Asia and is one of the main causes of kidney failure in young adults in China. Statistics show that with approximately 5 million IgAN patients in China and over 100,000 newly diagnosed patients annually, there is a significant unmet clinical demand. Since NEFECON(R)'s first prescription was issued in Mainland China in May 2024, the product has demonstrated strong market performance. According to Everest Medicines' interim report, NEFECON(R) achieved RMB1.673 billion in sales within its first month, reflecting widespread recognition of its therapeutic benefits and the significant demand for innovative therapies among Chinese patients.With NEFECON(R)'s successful inclusion in the NRDL, its accessibility and coverage in China are expected to increase significantly, driving sustained and robust commercial revenue growth for Everest Medicines. This milestone not only strengthens the company's leadership in nephrology but also injects new momentum into optimizing resource allocation and promoting synergistic development. As reimbursement coverage leads to expanded market penetration, this development is poised to be a key catalyst in unlocking the full value of the company's core products, further accelerating the reevaluation of its market potential.NEFECON(R) included in the NRDL is a testament to Everest Medicines' differentiated commercial strategy. Another core product, XERAVA(R) (eravacycline) is the world's first fluorocycline antibiotic for the treatment of complicated intra-abdominal infections, continues to excel in the field of complicated intra-abdominal infections. According to the recently released final report of the "Comprehensive Evaluation Project on the Clinical Application of Eravacycline", the drug demonstrated an impressive overall treatment effectiveness rate of 90.1%, further affirming its clinical value and safety. As of the first half of 2024, XERAVA(R) achieved cumulative sales of RMB2.33 billion, underscoring its strong market acceptance and potential.In the autoimmune disease portfolio, VELSIPITY(R) continues to make steady progress in its commercialization journey. In October, under the "Hong Kong and Macau Medicine and Equipment Connect" policy, VELSIPITY(R) received approval from the Guangdong Provincial Medical Products Administration and is now available for use in three designated medical institutions within the Greater Bay Area. Earlier this year, VELSIPITY(R) was also approved for use in Macau and Singapore. In addition, Everest Medicines recently submitted a new drug application (NDA) for VELSIPITY(R) in Hong Kong and plans to submit an NDA in Mainland China by the end of the year. As Everest Medicines' third commercialized product, VELSIPITY(R) is poised to become a key growth driver, with significant market potential expected to unfold as its adoption expands further.Everest Medicines continues to make significant strides in innovative R&D, with its proprietary mRNA development platform now fully localized. The company's first personalized mRNA cancer vaccine, EVM16, has Initiated an Investigator-Initiated Clinical Trial (IIT). Additionally, EVER001, a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor being developed globally for the treatment of renal diseases, marks another important advancement. Everest Medicines will host an investor call on December 4th to discuss the results of the Phase 1b/2a clinical study of EVER001 in primary membranous nephropathy, highlighting its potential to drive future growth.Driven by the inclusion of NEFECON(R) in the NRDL and the continued progress of its core pipeline, Everest Medicines' business model demonstrates its resilience and strength. The company remains steadfast in fulfilling its commitments to investors while strengthening market confidence in its innovation and long-term growth potential. With a diversified focus on renal, infectious, and autoimmune diseases, Everest Medicines is harnessing its robust commercialization platform to fuel growth, steadily advancing toward its vision of becoming Asia's leading global biopharmaceutical company. Copyright 2024 ACN Newswire via SeaPRwire.com.

Niyo Doubles Click-Through Rates and Improves Customer Retention with CleverTap

SAN FRANCISCO, CA & MUMBAI, Nov 28, 2024 - (ACN Newswire via SeaPRwire.com) - Niyo, India’s leading fintech startup, teamed up with CleverTap, the all-in-one engagement platform, to improve customer experiences through personalized engagement and real-time interactions. Since its founding in 2015, Niyo has been revolutionizing financial services in India, particularly with its international travel cards and app-based financial services, catering to the evolving needs of its users.In its almost decade-long journey, Niyo recognized the challenges that modern Indian travellers face at every touchpoint while venturing abroad. It sought a feature-rich user engagement platform that would effectively deliver the right solutions to its customers and found the ideal partner in CleverTap. By leveraging CleverTap’s advanced automation tools, Niyo enhanced its onboarding processes, while ensuring compliance with regulations, and streamlining customer experiences. This collaboration empowered Niyo to reduce drop-offs during the customer journey, automate personalized messages, and re-engage dormant users.By deploying CleverTap’s integrated platform, Niyo achieved:・2x increase in click through rates, leveraging Clever.AI for emotionally intelligent content.・40% optimized conversion rate through pinpoint targeting, ensuring personalized and relevant communication at every step.・12% re-engagement of dormant users through targeted campaigns, highlighting Niyo’s success in winning back inactive customers.Sushanth Ravikumar, SVP - Head of Marketing,  Niyo, said - “At Niyo, delivering a seamless and personalized experience for our customers is a top priority. CleverTap has been instrumental in elevating this experience. Its robust automation and communication tools have streamlined our onboarding process while maintaining compliance in the highly regulated sector. What started as a tool to streamline everyday operations has become a key force in helping us preserve customer trust, even during challenging times. Its ability to adapt to real-time shifts in customer engagement offers us a definitive edge in an ever-changing dynamic, solidifying our long-term confidence in the platform.”Sidharth Pisharoti, Chief Revenue Officer, CleverTap, said - “We are excited to collaborate with Niyo as they continue to innovate in the travel fintech space. Through our partnership, we’ve been able to enhance Niyo’s customer engagement by focusing on delivering personalized and timely experiences. This has not only streamlined their processes but also improved customer satisfaction, particularly in key areas like onboarding and transaction management. We look forward to supporting Niyo as they scale and evolve their offerings in this dynamic market.”About Niyo Niyo is India’s leading banking fintech that has revolutionized "travel banking" for Indians. The company was co-founded by banking veteran Vinay Bagri (currently, CEO) and technology veteran Virender Bisht (currently, CTO) in 2015. Niyo offers zero forex debit and credit cards, which provides the best banking experience and value for international travellers. This unique solution was invented by Niyo in 2015 and has helped over 2 million Indians by saving more up to 5% on their international transactions with Zero Forex offering.  In this last Series-C round in 2022, Niyo raised $130 million, which was led by global VC and PE firms, Accel, Lightrock, and Multiples. Its other investors include Prime Venture Partners, Horizons Ventures, Tencent, JS Capital, Social Capital, and Beams Fintech Fund. Niyo operates out of a corporate office in Bengaluru and has a sales presence in more than 20 states and union territories.Visit: GoNiyo.comAbout CleverTapCleverTap is the leading all-in-one customer engagement platform that helps brands unlock limitless customer lifetime value. CleverTap is trusted by over 2000 brands like Decathlon, Domino’s, Levis, Jio, Emirates NBD, Puma, Croma (A Tata Enterprise), Swiggy, SonyLIV, Axis Bank, AirAsia, TD Bank, Ooredoo, and Tesco, to help build personalized experiences for all their customers. The platform is powered by TesseractDB™ – the world’s first purpose-built database for customer engagement, offering speed and cost efficiency at scale.Backed by top-tier investors such as Accel, Peak XV Partners, Tiger Global, CDPQ and 360 One, the company is headquartered in San Francisco, with presence across Seattle, London, São Paulo, Bogota, Mexico, Amsterdam, Sofia, Dubai, Mumbai, Bangalore, Singapore, Vietnam, and Jakarta.For more information, visit CleverTap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/  X: https://twitter.com/CleverTap  Forward-Looking StatementsSome of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.For more information:SONY SHETTYDirector, Communications and CSR, CleverTap+91 9820900036sony@clevertap.com  ASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co  Copyright 2024 ACN Newswire via SeaPRwire.com.

Dmall Inc. Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

HONG KONG, Nov 28, 2024 - (ACN Newswire via SeaPRwire.com) - China’s largest retail digitalization solution provider – Dmall Inc. (“Dmall” or the “Company”, Stock Code: 02586.HK), today announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange”).Dmall plans to offer 25,774,000 Shares (subject to the over-allotment option), of which 23,196,600 Shares will be International Offer Shares (subject to reallocation and the over-allotment option), representing approximately 90% of the initial offer shares; the remaining 2,577,400 Shares will be Hong Kong Offer Shares (subject to reallocation), representing approximately 10% of the initial offer shares. The Offer Price is HK$30.21 per Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027%, Hong Kong Stock Exchange trading fee of 0.00565% and Accounting and Financial Reporting Council transaction levy of 0.00015% (payable in full on application in Hong Kong dollars and subject to refund).Dmall will open for Hong Kong Public Offering in Hong Kong at 9 a.m., November 28, 2024 (Thursday), and close at 11:30 a.m., December 3, 2024 (Tuesday). Dealings in shares of Dmall on the Main Board of the Hong Kong Stock Exchange is expected to commence on December 6, 2024 (Friday). The shares will be traded in board lot of 100 shares each. The Company’s stock code will be 02586.HK.UBS Securities Hong Kong Limited, CMB International Capital Limited and China Merchants Securities (HK) Co., Limited are the Joint Sponsors. UBS AG Hong Kong Branch, CMB International Capital Limited, China Merchants Securities (HK) Co., Limited, CLSA Limited and China International Capital Corporation Hong Kong Securities Limited are the Joint Global Coordinators, Overall Coordinators, Joint Bookrunners and Joint Lead Managers.After deducting the underwriting commissions and other estimated offering expenses payable by the Company, with an Offer Price of HK$30.21 per Offer Share, the Company estimates that it will receive net proceeds of approximately HK$623.7 million from the Global Offering after deducting the underwriting commissions and fees, and other estimated expenses in connection with the Global Offering and assuming that the Over-allotment Option is not exercised. In line with Dmall’s strategies, the proceeds from the Global Offering are intended to be used for the following purposes and in the following amounts – approximately 42.1%, or HK$262.6 million, to develop new applications and new service modules; approximately 30.0%, or HK$187.1 million, for talent acquisition associated with the expansion of Dmall’s operations; approximately 10.0%, or HK$62.4 million, to selectively pursue strategic cooperation, investments and acquisitions that are complementary to its organic growth strategies, particularly those that can complement Dmall’s product offerings, strengthen its technology capabilities, and solidify its market position; approximately 7.9%, or HK$49.3 million, to expand its sales network and further strengthen its brand reputation; and approximately 10.0%, or HK$62.4 million, for working capital and general corporate purposes.Dmall was founded in 2015, which provides retail digitalization solutions to retailers in the local retail industry. According to Frost & Sullivan, Dmall is the largest retail cloud solution provider in China by GMV, with a market share of 13.3% in 2023. The expansion has allowed the Company to become the largest retail cloud solution provider in Asia by GMV in 2023, occupied a market share of 10.9%, according to Frost & Sullivan.As a leading retail digitalization solution provider in Asia, the broadest operational modules coverage enables Dmall to cover diverse customer base in the retail industry and thus obtain deep retail know-how, meet the needs of all major aspects of the retailer's operations. Dmall served 444 customers in the six months ended June 30, 2024, such as Pangdonglai, Luosen (China), Dennis and Maidelong Entities, as well as well-known brands such as Wellcome, Mannings, Guardian, Giant and 7-Eleven (Hong Kong), which operate under the DFI Retail Group, demonstrating a widely validated operating model. The dollar-based net retention ratio was 184% in 2021, 158% in 2022, 117% in 2023 and 123% in the twelve months ended June 30, 2024, remaining robust at above 100%, which underscores Dmall’s ability to further increase customer spending.Dmall has always attached importance to the value created for customers, “customer success” is the starting point of everything the Company does. Dmall has provided services to leading companies in different retail formats, and has successfully expanded its businesses markets outside of the Chinese mainland, comprising Hong Kong SAR, Cambodia, Singapore, Malaysia, Poland, Macau SAR, Indonesia, the Philippines and Brunei. In terms of income, the overseas income of the Company in 2023 has exceeded RMB100 million.Dmall achieved strong revenue growth as its revenue grew by 56.6% from RMB848.2 million in 2021 to RMB1,328.3 million in 2022, and further increased by 19.4% to RMB1,585.4 million in 2023. Dmall’s revenue increased by 22.9% from RMB764.0 million in the six months ended June 30, 2023 to RMB939.2 million in the six months ended June 30, 2024. Dmall has also improved its gross margin during the Track Record Period. Dmall’s gross margins were 20.4%, 38.0%, 35.0%, 36.3% and 38.3% in the years ended December 31, 2021, 2022, 2023 and the six months ended June 30, 2023 and 2024, respectively.Mr. Zhang Feng, co-founder, executive Director and president of Dmall said, “We empower retailers to thrive in the digital era and are committed to becoming the world's leading omnichannel retail digital solutions provider. We will uphold the values of "continuous innovation", always strive, constantly strengthen and uphold our own technical barriers and optimize products and services, maintain core competitiveness, continue to provide customers with high-value services, and help customers' business. We look forward to taking the listing as an opportunity to fully leverage our competitive advantages and utilize Hong Kong's unique financing platform to further enhance our strengths and continue to create greater value for our shareholders and investors.”Issued by Porda Havas International Finance Communications Group for and on behalf of Dmall Inc. For further information, please contact:Porda Havas International Finance Communications GroupMS.Fung Kelly(852) 3150 6763kelly.fung@h-advisors.globalMS.Wang Evie(86) 135 2006 8960evie.wang@h-advisors.global  Copyright 2024 ACN Newswire via SeaPRwire.com.

Edvantage Group Announces FY2024 Annual Results

Highlights (relevant audited data for the year ended 31 August 2024)- Revenue increased by 17% YoY to approximately RMB2,312 million;- Gross profit rose by 10% YoY to approximately RMB1,124 million;- Profit for the period attributable to owners of the Company rose by 16% YoY to      approximately RMB715 million;- Number of student enrolments increased by 11% YoY to approximately 95,600;- Payment of a final dividend of HK10.0 cents per share;- Dividend payout ratio of 30% for the year.HONG KONG, Nov 29, 2024 - (ACN Newswire via SeaPRwire.com) - Edvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK) has announced its audited FY2024 Annual Results for the year ended 31 August 2024 (the “Reporting Period”). During the Reporting Period, the Group actively responded to national policies, vigorously promoted industry-education integration, deepened the connotations of international education, continued to introduce unique new featured majors that match market and industry demands and fully embraced artificial intelligence (“AI”), succeeding in raising education quality and brand presence, thereby achieving steady growth in performance year after year.During the Reporting Period, the Group’s revenue totaled approximately RMB2,312 million, representing an increase of 17% as compared to the corresponding period of the preceding year. The increase was mainly attributable to the continuous enhancement of the Group’s education brand effectiveness, which drove a rise in the number of student enrolments and higher average tuition fees recorded by the Group’s domestic schools. Profit for the period attributable to owners of the Company rose by 16% YoY to approximately RMB715 million. The number of students enrolled in the Group’s schools continued to expand yearly, reaching approximately 95,600, with a year-on-year growth of approximately 11%. The Board of Directors of the Group has recommended the payment of a final dividend of HK10.0 cents per share for the year ended 31 August 2024, which, along with an interim dividend of HK9.6 cents per share, equates to a total annual dividend of HK19.6 cents per share and a dividend payout ratio of 30% for the year.From left to right: Mr. Yan Kwok Ting Sunny, Director of Investment, Corporate Finance & Investor Relations Department;Mr. Liu Yuk Tung, ChiefFinancial Officer; Ms. Liu Yi Man, Executive Director and Chief Executive Officer;Ms. Liu Wenqi, Chief Operating Officer;Fully embracing AI and continuously promoting the industry-education integrationOver the past year, the Group witnessed the groundbreaking development of the new generation of artificial intelligence technology. As a vocational education provider, the Group has developed in step with times, fully embracing AI in teaching, management and application. At present, all of its schools are actively promoting AI, fostering its popularity, with AI-embedded courses launched in seven colleges. Subsequent efforts will be made to promote those programmes to cover all faculties and students of all schools under the Group. Meanwhile, the Group actively responded to national policies, continuously deepened industry-education integration, and fully promoted the construction of industrial colleges, cooperating with multiple enterprises renowned in their respective industries to establish artificial intelligence and big data, digital trade, digitalised accounting and business services, research and tourism, jewelry, human resources and other industrial colleges. Those industrial colleges are all set up according to the Ministry of Education requirements for building modern industrial colleges that align with the country’s key industry development strategies, in order to nurture high-quality application-minded talent that emerging industries urgently need. In addition, the Group also entered into school-enterprise cooperation with numerous enterprises to build off-campus practice bases, further promoting the in-depth integration of education chains and industrial chains.Expanding exchange and cooperation of international education and deepening the connotations of international educationThe Group responded to the national advocacy for the opening up of education, “introduction of foreign schools”, and “international expansion of domestic schools”, continuously promoted the internationalisation of vocational education and expanded the partnership network with global renowned universities. By providing high-quality international programs and practice opportunities to students, the Group aims to cultivate innovative talents with global vision, to further raise the international influence of China’s vocational education. During the Reporting Period, the schools under the Group established in-depth cooperation with 51 foreign high schools in the United States of America, the United Kingdom, Canada, Japan and Australia, joining hands to create diverse high-quality international programmes. Furthermore, the Group comprehensively launched international study tours, organising 65 student and teacher study tours to France, Singapore, Hong Kong, China, Macau, China and other regions for short-term studies, with over 4,000 teachers and students participating during the Reporting Period. Looking forward, the Group will press on with deepening integration of its schools - domestic and international, strive to build a diversified international education cooperation network, actively promote Chinese vocational education to go global and build an internationally renowned Chinese vocational education brand.Consistently increasing investment in education to build a high-quality education brandThe Group has always adhered to the motto of "Establishing school of the century, Nurturing talents of the nation". Firmly believing that increasing investment in education is an important path towards high-quality education, the Group further expanded the new campus of Guangzhou Huashang College and Guangzhou Huashang Vocational College during the Reporting Period, which includes student dormitories, library, sports centre, teaching buildings and laboratories, providing solid support for future student enrollment and sustainable development of the Group. At the same time, it has kept increasing investment in building a high-quality teaching staff, which has expanded after the Guangzhou Huashang College and Guangzhou Huashang Vocational College established their Guangdong Province Doctoral Workstation respectively. The Group has launched a series of training workshops for teachers to continuously enhance their professionalism and practical teaching abilities, encouraging them to practice what they have learned and help improve school education and teaching quality. By introducing mentors from industries, it works together with enterprises in nurturing professional “dual-qualified” teachers and “dual-skilled” industry mentors, continuing to optimize the combined structure of full-time and part-time faculty teams. The in-depth and precise investment made by the Group in various areas crucial to strengthening school management has brought bountiful results. Guangzhou Huashang College placed third in scientific research competitiveness among private undergraduate colleges in China and has been designated as a key research base for humanities and social sciences among regular higher education institutions in Guangdong Province. Guangzhou Huashang Vocational College has been named a national exemplary vocational college, while the Urban Vocational College of Sichuan ranked second in China and first in Sichuan among Shanghai Ranking's 2024 Best Chinese Private Higher Vocational Colleges. These honors are a strong testament to the Group’s high-quality educational achievements.Looking ahead, the Group will continue to nurture innovative talent, focusing on such areas as industry and education integration, internationalization, and AI to keep up with industry and social development needs, increase investment in education, and keep building a high-quality education brand. It is committed to nurturing highly-skilled interdisciplinary corporate leaders for the country and industries around the world, while continuously making positive contributions to the sustainable development of vocational education.About Edvantage Group Holdings LimitedEdvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK) is the largest private business higher education and vocational education group in the Greater Bay Area, and an early mover in education sector in pursuing international expansion, listed in Hong Kong Main Board on 16 July 2019. The total number of full-time student enrolments of the Group was approximately 96,000 as of 31 August 2024. Operated 9 private education institutions, namely, Guangzhou Huashang College (Applied Undergraduate), Guangzhou Huashang Vocational College (Higher Vocational Education) and Guangdong Huashang Technical School (Secondary Vocational Education) located in Guangdong Province, the PRC; Urban Vocational College of Sichuan (Higher Vocational Education) and Urban Technician College of Sichuan (Secondary Vocational Education) in Sichuan Province, the PRC; GBA Business School (GBABS) in Hong Kong, the PRC; Global Business College of Australia (GBCA) and Edvantage Institute Australia (EIA) in Australia; as well as Edvantage Institute (Singapore) (EIS) in the downtown of Singapore.While focusing on school operations, the Group also actively fulfil corporate social responsibility, extensively contributing to social welfare programmes including charity, poverty alleviation, education and revitalisation, in order to take the initiative in repaying society through action. Since its listing, the Group has made outstanding contributions in the field of ESG and has won the “Best ESG Innovation Award” from Zhitong Finance and the “Outstanding Enterprise for ESG Innovative Practice” from Gelonghui in 2024. Copyright 2024 ACN Newswire via SeaPRwire.com.

Aqua free Industries擴大其全球先進OEM水過濾解決方案的設施和能力

(SeaPRwire) -   漢堡,[2024年11月28日] – Aqua free Industries,創新的飲用水衛生解決方案領導者,隨著其位於比利時隆美爾的尖端設施落成,開啟了新篇章。這個最先進的廠區不僅樹立了研發的新標準,還將公司的生產能力提高了一倍,以滿足對先進膜過濾器的日益增長的需求。此項戰略舉措強化了 Aqua free Industries 通過量身定制的 OEM 合作夥伴關係,為全球眼光獨到的客戶提供高度專業化過濾解決方案的承諾。 作為航空和醫療保健行業值得信賴的合作夥伴,Aqua free Industries 再次憑藉PuriFLY 飛機飲用水過濾器展現其創新能力。這款新型過濾器技術採用特殊研發的膜,可去除99.99999% 的所有細菌,根據嚴格的 ASTM F838 細菌截留標準進行測試。集成的活性炭元件進一步減少氯、異味、有機化合物和重金屬。 PuriFLY 過濾器最大流量為 10 l/min,工作壓力高達 5 bar,具有卓越的性能。比較測試表明,與傳統過濾器相比,壓力損失顯著降低,確保高效利用。PuriFLY 過濾器與現有過濾器外殼兼容,實現無縫集成。它代表了航空業衛生標準的巔峰,標誌著先進過濾器解決方案開發的又一個里程碑。 Aqua free Industries 與德國漢莎航空技術公司 (Lufthansa Technik) 緊密合作,開發出具有突破性的兩級過濾系統,顯著提高了機上水質,同時降低了維護要求。PuriFLY 過濾器可以輕鬆集成到現有系統中,例如 General Ecology 系列 (AC3),並提供出色的流量和最小的壓力損失——這對航空業來說是一個真正的優勢。 “我們在比利時的新的廠區使我們能夠更靈活地響應客戶的需求,同時保證最高的衛生標準,”Aqua free Industries 常務董事 Gregor Krey 說。“與德國漢莎航空技術公司 (Lufthansa Technik) 成功開發兩級過濾器,是我們致力於 OEM 合作夥伴關係的完美典範。這樣的合作突顯了我們不僅能夠提供創新產品,還能夠創造真正產生影響的定制解決方案的能力。”憑藉其在隆美爾的新廠區和對全球 OEM 合作夥伴關係的加強關注,Aqua free Industries 已做好準備,引領膜過濾器技術市場。公司始終致力於確保關鍵應用中的用水安全,鞏固其在該領域的全球領導地位。 關於 Aqua free GmbH 和 Aqua free Industries BV: Aqua free GmbH 是歐洲領先的用水衛生製造商之一。自 1999 年以來,這家家族企業在飲用水質和健康保護方面樹立了新的標準。憑藉創新的過濾器和消毒解決方案,Aqua free 保護醫院、護理機構、住宅建築和工業設施免受水源性感染,減少嗜肺菌和其他微生物。ISO 9001、14001 和 13485 認證突顯了其對品質的承諾。Aqua free Industries 作為同一企業集團的成員,專注於膜過濾器和定制 OEM 解決方案。公司為幾個歐洲國家的客戶提供全面的服務,從定制飲用水衛生解決方案的開發到實施。 更多信息,請訪問 或聯繫: Aqua free GmbH Margaretha Gesler市場和傳播主管電話:+49 170 496 79 85電子郵件: Winsbergring 3122525 漢堡德國 www.aqua-free.com 1 General Ecology 以 Versa-Pure® 品牌提供各種航空業用水處理和過濾系統。這些系統設計用於飛機廚房和衛生間,並提供諸如水處理、顆粒過濾、風味和氣味去除以及水垢控制等功能。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

奧斯汀科技集團宣佈臨時股東大會結果 “`

(SeaPRwire) -   中國南京,2024年11月27日 -- Ostin Technology Group Co., Ltd.(「本公司」)(納斯達克股票代碼:OST),一家位於中國的領先顯示模組和偏光片供應商,宣佈了於2024年11月26日上午10:00(北京時間)(美國東部時間2024年11月25日晚上9:00)在其位於中國江蘇省南京市棲霞區紫東路1號F4大樓1樓的行政辦公室舉行的臨時股東大會的結果。 在臨時股東大會上,本公司的股東: 批准並追認委任Audit Alliance LLP為本公司截至2024年9月30日止財政年度的獨立註冊公共會計師事務所,並授權董事會和/或審計委員會確定該獨立註冊公共會計師事務所的年度報酬;批准本公司已授權股本為500,000美元,分為4,991,000,000股面值為0.0001美元的A類普通股、8,000,000股面值為0.0001美元的B類普通股和1,000,000股面值為0.0001美元的優先股,按1股換10股的比例進行合併和分割(「股份合併」);授權本公司的過戶代理人和股份登記處根據需要更新本公司的已登記成員名冊以反映股份合併;並授權本公司的註冊辦事處提供者就股份合併向開曼群島公司註冊處進行任何必要的申報;通過以本公司經修訂及重述的第三號章程細則取代並排除現有經修訂及重述的第二號章程細則全文,作為本公司的章程細則,立即生效,以反映股份合併;授權本公司的註冊辦事處提供者就通過經修訂及重述的第三號章程細則向開曼群島公司註冊處進行任何必要的申報;並且關於股份合併所產生的任何及所有已發行合併股份的零碎權益,授權董事會以其認為方便的方式解決與股份合併相關的任何困難,包括但不限於:將股份合併後向本公司股東發行或註冊的股份零碎部分四捨五入至最接近的整數股,和/或將目前計入本公司任何儲備或基金(包括其股本溢價賬戶和損益賬戶)貸方的任何金額的全部或部分資本化,無論該金額是否可用於分派,並將該款項用於支付將發行的未發行股份,以將股份合併後向本公司股東發行或註冊的股份零碎部分四捨五入至最接近的整數股。 關於Ostin Technology Group Co., Ltd.本公司成立於2010年,是中國的顯示模組和偏光片供應商。本公司設計、開發和製造各種尺寸和客製化尺寸的TFT-LCD顯示模組,主要用於消費電子產品、戶外LCD顯示器和汽車顯示器。本公司還生產用於TFT-LCD顯示模組的偏光片。 更多資訊,請瀏覽 前瞻性聲明本新聞稿包含1995年《私人證券訴訟改革法案》所定義的前瞻性聲明。前瞻性聲明包括關於計劃、目標、策略、未來事件或業績、基本假設以及其他非歷史事實陳述的聲明。當本公司使用諸如「可能」、「將會」、「打算」、「應該」、「相信」、「預期」、「預計」、「計劃」、「估計」或其他與非歷史事項相關的類似表達時,即表示本公司正在作出前瞻性聲明。前瞻性聲明並不能保證未來的業績,並涉及可能導致實際結果與本公司在前瞻性聲明中討論的預期存在重大差異的風險和不確定性。這些聲明受不確定性和風險的影響,包括但不限於:本公司的目標和策略;本公司對市場趨勢的預測;本公司未來的業務發展;對新產品的需求和市場接受度;預期收到新產品的客戶訂單;新產品的營銷和銷售的預期時間;技術的變化;本公司吸引和留住熟練專業人員的能力;客戶集中度;以及影響本公司行業的總體經濟狀況以及與上述任何事項相關或與之相關的假設以及本公司向美國證券交易委員會提交的報告中包含的其他風險。基於這些原因以及其他原因,投資者應謹慎,不應過度依賴本新聞稿中的任何前瞻性聲明。其他因素在本公司提交給美國證券交易委員會的文件中有所討論,這些文件可在 處查看。本公司不承擔公開修訂這些前瞻性聲明以反映此日期之後發生的事件或情況的義務。 更多資訊,請聯繫:Ostin Technology Group Co., Ltd. 投資者關係:Janice WangWealth Financial Services LLC電話:+86 13811768599 +1 628 283 9214電郵:本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

WORK Medical Technology Group LTD子公司杭州善友在2024年MEDICA醫療展覽會上展示產品

(SeaPRwire) -   中國杭州,2024年11月27日 -- WORK Medical Technology Group LTD (Nasdaq: WOK)(「WORK Medical」或「公司」),一家中國醫療器械供應商,今日宣佈其子公司杭州善友醫療器械有限公司(「杭州善友」)參加了2024年德國杜塞爾多夫舉行的MEDICA醫療展(「展會」),展會時間為2024年11月11日至11月14日。展會為杭州善友的產品提供了讓國際客戶產生興趣和關注的平台。這一里程碑突顯了WORK Medical致力於提升其全球品牌知名度,並在低值和中值醫療器械及耗材領域參與國際競爭的戰略承諾。 該展會邀請了來自商界、研究界和政界的參與者。展會吸引了來自全球72個國家的5800家參展公司。此外,專業論壇和會議已成為展會不可或缺的一部分,展會還包括關於各種醫療技術主題的專題展覽。 在展會期間,杭州善友展示了一系列其旗艦產品,包括其非充氣喉罩、呼吸迴路和氣管插管。這些產品展示了WORK Medical的技術進步,其基礎是公司在醫療器械行業超過20年的專業知識。展會為杭州善友提供了吸引潛在全球客戶興趣並深入了解其特定需求的機會。公司預計,這些見解將指導其產品組合的持續改進,並可能引導其研發工作,以幫助其全球擴張戰略與醫療器械行業不斷變化的需求相符。 WORK Medical董事長兼首席執行官吳爽先生評論道:「隨著我們探索推動擴張和長期成功的全球機會,展會是一個絕佳的平台,可以展示我們的產品,提升我們的品牌形象,並與國際同行交流對行業趨勢、技術和創新的見解。展望未來,我們致力於加速國際化,力求獲得更多全球訂單,並通過利用我們的生產和規模優勢為股東創造更大的價值。」 關於WORK Medical Technology Group LTD WORK Medical Technology Group LTD 是一家醫療器械供應商,開發和生產一類和二類醫療器械,並通過其在中國的運營子公司銷售一類和二類一次性醫療器械。公司擁有一個多元化的產品組合,包括21種產品,包括定制和多功能口罩以及其他醫療耗材。所有產品已銷售到中國34個省級行政區,其中15種產品已銷售到全球30多個國家/地區。公司獲得多項與質量相關的生產資格,並已向美國食品藥品監督管理局註冊了17種產品,允許其產品進入美國市場。更多信息,請訪問公司網站: 。 前瞻性聲明 本新聞稿包含前瞻性聲明,包括根據1995年《私人證券訴訟改革法案》的安全港條款作出的聲明。這些聲明可以用「目標」、「預期」、「相信」、「可能」、「估計」、「預計」、「預測」、「目標」、「打算」、「可能」、「計劃」、「潛在」、「可能」、「尋求」、「將」以及這些詞語的變體或旨在識別前瞻性聲明的類似表達來識別。本新聞稿中任何非歷史事實的聲明均可被視為前瞻性聲明。 本新聞稿中的任何前瞻性聲明僅基於公司截至本新聞稿發布之日的當前預期、估計和預測,並受多種風險和不確定因素的影響,這些風險和不確定因素可能導致實際結果與前瞻性聲明中陳述或暗示的結果存在重大差異。雖然公司相信這些前瞻性聲明中表達的預期是合理的,但公司不能向您保證這些預期將被證明是正確的,並且公司告誡投資者,實際結果可能與預期結果存在重大差異,並鼓勵投資者審閱可能影響其未來結果的其他因素,這些因素已載於公司的F-1表格註冊聲明和其他公司向美國證券交易委員會提交的文件中。除法律規定外,公司明確放棄更新任何前瞻性聲明的義務。 更多信息,請聯繫: WORK Medical Technology Group LTD投資者關係部門電子郵件:  Ascent Investor Relations LLC蕭婷娜電話:+1-646-932-7242電子郵件: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Mobile-health Network Solutions將於2024年12月3日至4日出席Noble Capital Markets第二十屆新興成長股權投資會議 “`

(SeaPRwire) -   新加坡,2024年11月27日 --  Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” 或 “the Company”), 一家領先的亞太地區遠程醫療提供商,今日宣佈其聯合創始人兼聯合首席執行官Rachel Teoh博士和Siaw Tung Yeng博士將於12月4日星期三東部標準時間下午12時30分在佛羅里達大西洋大學行政教育中心參加NobleCon20 - Noble Capital Markets第二十屆新興增長股票會議。 演講的高清視頻網絡直播將於次日在公司網站上提供,並作為Noble Capital Markets會議網站上提供的完整演講目錄的一部分:以及Noble創建的投資者門戶網站Channelchek上。網絡直播將在公司網站、NobleCon網站和Channelchek.com上存檔90天。 關於Mobile-health Network Solutions 在《金融時報》2024年亞太地區500家高增長公司榜單中排名第41位,我們是首家在美國上市的亞太地區遠程醫療提供商。通過我們的MaNaDr平台,我們為全球用戶提供個性化和可靠的醫療服務。我們的平台讓我們的醫療服務提供商社區能夠通過虛擬診所接觸更廣泛的用戶,而無需任何啟動成本,並能夠連接到全球點對點支持團體和合作夥伴網絡。我們提供的無縫且便捷的遠程醫療解決方案包括遠程會診服務、處方藥履行和其他個性化服務,例如體重管理計劃和性別特定護理。更多信息,請訪問 。 關於Noble Capital Markets, Inc. Noble Capital Markets成立於1984年,是一家獲得美國證券交易委員會/金融行業監管局註冊的綜合性投資銀行和顧問公司,擁有一支屢獲殊榮的研究團隊和專有的投資者分銷平台。我們為企業家、公司、金融贊助商和投資者提供中端市場專業知識。在過去40年中,Noble為公司籌集了數十億美元資金,並發布了超過45,000份股票研究報告。Noble於2018年推出了 -一個專門致力於公開新興增長公司及其行業的投資者社區。Channelchek是首個免費向所有級別的公眾提供機構級研究的服務,無需訂閱。該網站上列出了7,000多家公開上市的新興增長公司,以及包括股票研究、網絡直播和行業文章在內的內容。 前瞻性聲明 本新聞稿中關於未來預期、計劃和前景的某些聲明,以及任何其他關於非歷史事實事項的聲明,可能構成1995年《私人證券訴訟改革法案》意義上的“前瞻性聲明”。這些聲明包括但不限於與預期交易開始和結束日期相關的聲明。“預期”、“相信”、“繼續”、“可能”、“估計”、“預計”、“打算”、“可以”、“計劃”、“潛力”、“預測”、“項目”、“應該”、“目標”、“將”、“願意”等類似詞語旨在識別前瞻性陳述,儘管並非所有前瞻性陳述都包含這些識別詞語。前瞻性陳述並非未來業績的保證,並涉及可能導致實際結果與前瞻性陳述中討論的公司預期存在重大差異的風險和不確定性。這些聲明受不確定性和風險的影響,包括但不限於:公司執行戰略、管理增長和保持公司文化的能力;公司的未來業務發展、財務狀況和經營成果;關於公司產品和服務的需求和市場接受度的預期;技術變化;經濟狀況;新加坡及公司計劃服務的其他國際市場遠程醫療解決方案行業的增長;聲譽和品牌;競爭和定價的影響;政府法規;新加坡及公司計劃服務的其他國際市場的整體經濟和商業狀況的波動以及任何上述事項或與上述事項相關的其他風險,這些風險包含在公司向美國證券交易委員會提交的報告中。出於這些原因以及其他原因,提醒投資者不要過度依賴本新聞稿中的任何前瞻性陳述。本新聞稿中包含的任何前瞻性聲明僅在本新聞稿發布之日有效,Mobile-health Network Solutions明確否認更新任何前瞻性聲明的義務,無論是基於新信息、未來事件還是其他原因,除非法律要求。 媒體查詢,請聯繫:Mobile-health Network Solutions 投資者關係聯繫人:2 Venture Drive, #07-06/07 Vision Exchange新加坡 608526(+65) 6222 5223電郵:  投資者關係查詢:Skyline Corporate Communications Group, LLCScott Powell, 總裁1177 Avenue of the Americas, 5th Floor紐約,紐約州 10036辦公室:(646) 893-5835電郵: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Trescon’s World Blockchain Summit Rebrands to HODL, Signalling a Bold New Era for Innovations in Blockchain and Beyond

DUBAI, UAE, Nov 28, 2024 - (ACN Newswire via SeaPRwire.com) - Since its inception in 2017, the World Blockchain Summit (WBS) has grown into the world’s longest-running and most prestigious blockchain and Web3 event series, hosting 29 successful editions across 16 countries. Over the years, WBS has established itself as a key platform that unites global innovators, investors, and policymakers to shape the future of decentralised technology. Today, Trescon proudly announces the evolution of this iconic event with a bold rebranding to HODL, a name that embodies resilience, progress, and the limitless potential of blockchain and Web3 ecosystems.HODL will make its highly anticipated debut at the 30th global edition of the summit in Dubai, UAE, on April 28-29, 2025. This rebranding marks a significant shift toward positioning the event as a premier platform for serious business, innovation, and deal-making in the blockchain space.Why the RebrandThe transition from WBS to HODL reflects the evolution of the event from a conference series to a strategic platform driving real business outcomes. HODL now embraces not only blockchain but also the broader horizons of innovation and collaboration within Web3, crypto, and emerging decentralised systems. The focus is on creating meaningful connections between ground-breaking blockchain projects, pre-qualified investors, enterprise leaders, and government regulators. This shift reflects a commitment to facilitating collaborations that will shape the future of the blockchain industry.What to Expect at HODL 2025 in DubaiTrailblazing Thought Leaders: Hear from top blockchain innovators, industry pioneers, and government representatives shaping the future of blockchain and decentralised ecosystems.Deal-Making Opportunities: Engage with pre-qualified investors actively seeking the next big blockchain projects.Enterprise & Government Collaborations: Dive into discussions on regulatory frameworks, public-private partnerships, and enterprise adoption strategies for blockchain.Cutting-Edge Innovations: Witness live showcases of groundbreaking blockchain use cases, crypto solutions, and Web3 technologies from around the world.Dubai, known for its progressive blockchain policies and visionary leadership, is the perfect launchpad for the HODL brand. With Dubai’s commitment to becoming a global hub for blockchain and Web3 innovation, HODL is poised to make an unprecedented impact on the world of blockchain.QuotesMohammed Saleem, Founder and Chairman, Trescon, commented:“The rebranding of World Blockchain Summit to HODL marks a pivotal moment in our journey as we move beyond simply hosting events to becoming a true enabler of blockchain and Web3 innovation. With HODL, we aim to create a future-focused, results-driven platform that empowers projects, investors, and governments to collaborate meaningfully and shape the next era of decentralized technology.”Anil Kumar, COO, Trescon, added:“HODL isn’t just a rebrand—it’s a redefinition of what a blockchain event should be. It is a testament to our vision of facilitating real outcomes through deal-making, partnerships, and showcasing transformative blockchain solutions to the world. Dubai, with its ambitious blockchain agenda, is the perfect stage for this transition.”The Legacy of WBSFor nearly a decade, the World Blockchain Summit has led the way in blockchain adoption, creating a legacy as the longest-running Web3 event. The rebrand to HODL builds on this legacy, signalling a more strategic, business-centric approach to blockchain’s integration into industries and society.Join Us at HODL 2025 in DubaiMark your calendars for April 28-29, 2025, and join us in Dubai for HODL – The Vanguard of Blockchain and Beyond, where innovation meets opportunity.For more details and early registrations, visit: hodlsummit.com/dubai2025.About HODLHODL is an event by Trescon that supports the growth of the blockchain, crypto and Web3 ecosystem globally. It is the world's longest-running blockchain, crypto, and web 3-focused summit series. Since its inception in 2017, it has hosted more than 20 editions in 11 countries and strives to create the ultimate networking and deal flow platform for the Web3 ecosystem. Each edition brings together global leaders and emerging start-ups in the space, including investors, developers, IT leaders, entrepreneurs, government authorities, and others.About TresconTrescon is a global leader in business events, focusing on the adoption of emerging technologies and sustainable solutions. With a portfolio of industry-leading events, including HODL (formerly WBS), Trescon is dedicated to creating platforms that foster innovation, collaboration, and economic growth.Media Contact:Shadi DawiSenior DirectorPR, Comms., and Partnerships, Global & MEAE: shadi@tresconglobal.com | M: +971 55 498 4989 Copyright 2024 ACN Newswire via SeaPRwire.com.

LANGHAM BEAUTY Green Vitality

Download images: https://shorturl.at/o22GsHONG KONG, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - As the holiday season approaches, Champion REIT (Stock Code: 2778) is pleased to announce its “Green Vitality” festive campaign at its all-in-one beauty landmark, LANGHAM BEAUTY. It has unveiled the immersive sustainable Christmas decorations in collaboration with a local environmental art curation studio*. A Beauty Empties Recycling Programme was also launched, with a goal of promoting green lifestyle through innovative and diverse art while sharing festive joy with the community.Embracing Sustainability with Immersive Christmas DecorationsThis green Christmas campaign at LANGHAM BEAUTY presents "The Urban Oasis", a sustainable art installation created in collaboration with a local environmental art curation studio. This immersive display symbolises a tranquil green oasis amidst the bustling city, encouraging the public to connect with nature. Located on L1 of Langham Place, the nature-infused display features 250 recycled plastic decorations and reusable steel structures. As stepping in, visitors will be greeted by the soothing sounds of chirping birds and the fresh scent of Christmas trees, inviting them into an immersive natural healing experience. To promote sustainability, these Christmas trees and over 60% of the plants will be replanted and upcycled after the event, giving these beautiful plants a second life.*Earthero Studio is an environmental curation and consulting firm that uses art as a medium to convey ecological messages. In 2022, they organized Asia's first sustainable fashion art exhibition. The studio also operates a clothing brand that upcycles surplus fabrics and second-hand items into new, fashionable pieces.Partnering with V Cycle to Launch the Beauty Empties Recycling ProgrammeAnother highlight is the launch of “Green Vitality Beauty Empties Recycling Programme" in partnership with the eco-conscious social enterprise V Cycle. Through this initiative, the public can drop off empty plastic beauty product containers at the nature-inspired collection point on L2 of LANGHAM BEAUTY, from which the collected empty bottles will be processed and transformed into valuable resources by V Cycle.  This lush greenery backdrop also provides a perfect spot for photos while encouraging customers to embrace a greener lifestyle through collective recycling efforts.Introducing a New Beauty Zone with Leading International BrandsLANGHAM BEAUTY has recently completed its expansion with a new zone featuring a selection of high-quality international beauty brands. The new additions include Hong Kong's first Valentino Beauty counter; Hourglass, the American vegan makeup brand committed to animal rights; JSM Beauty, founded by South Korean legendary makeup artist Jung Saem Mool; Japan's prestigious skincare brand Albion; and Europe's luxurious Helena Rubinstein. These brands offer diverse beauty choices and exceptional customer experiences, reinforcing LANGHAM BEAUTY's status as a premier one-stop-for-all beauty destination.Innovative Services with the First 'Shop-to-Point' Seamless ExperienceTo make holiday shopping more convenient, LANGHAM BEAUTY has partnered with SF Express Hong Kong to launch the first beauty-themed "Shop-to-Point" service station in the city, offering free same-day delivery* with no minimum spend. Additionally, our e-store continues to expand product selection, ensuring a seamless shopping experience both in-store and online.  *Yau Tsim Mong District Exclusive. Order before 3pm for same-day delivery.From left: Ms. Christina Hau, CEO of Champion REIT and Ms Grace Chan Hoi Lam, Celebrity unveil the sustainable Christmas art installationFrom left: Mr Eric Swinton, Founder & CEO of V Cycle; Ms Bertha Shum, CEO of Earthero Studio;Ms Christina Hau, CEO of Champion REIT; Ms Grace Chan Hoi Lam, Celebrity;Ms Iris Li, General Manager of LANGHAM BEAUTY join the kick-off ceremonyThis Christmas, join us at LANGHAM BEAUTY to celebrate a sustainable holiday. Let's bring green ideas to life through our collective efforts and immerse ourselves in the creativity and vibrant green aesthetics of LANGHAM BEAUTY!LANGHAM BEAUTY “The Urban Oasis” Eco Christmas Art InstallationDate and time:27 November 2024 to 2 January 2025Monday to Thursday: 11:00 AM - 10:00 PMFriday to Sunday: 11:00 AM - 10:30 PMVenue:L1, Langham Place, Mongkok LANGHAM BEAUTY Green Vitality Beauty Empties Recycling ProgrammeDate and time:27 November 2024Monday to Thursday: 11:00 AM - 10:00 PMFriday to Sunday: 11:00 AM - 10:30 PMRecollection point:LANGHAM BEAUTY L2, Langham Place, MongkokAbout Champion REIT (2778)Champion Real Estate Investment Trust is a trust formed to own and invest in income-producing office and retail properties. The Trust focuses on Grade-A commercial properties in prime locations. It currently offers investors direct exposure to nearly 3 million sq. ft. of prime office and retail area. These include two Hong Kong landmark properties, Three Garden Road and Langham Place, as well as a joint venture stake in 66 Shoe Lane in Central London. The Trust has been awarded the top five-star rating by GRESB since 2023.About Langham BeautyLangham Beauty is a premier beauty concept store located on L1 & L2 of Langham Place in Mong Kok. It features over 60 top-tier brands in beauty, skincare, fragrance, haircare, and body care, including ARMANI BEAUTY, CHANEL BEAUTÉ, DIOR BEAUTY, ESTÉE LAUDER, LANCÔME, SHISEIDO, SK-II, and VALENTINO BEAUTY etc. Our mission is to transform customers' beauty journeys, providing a one-stop shopping experience that caters to the beauty aspirations of every woman. At Langham Beauty, we believe that staying true to oneself and embracing nature are the first step to achieving confidence and natural beauty.Langham Beauty breaks conventions by integrating three essential elements: human, nature, and technology, to present a diverse aesthetic. We are committed to environmental sustainability in beauty and leverage technological innovations to balance beauty consumption while giving back to nature. Langham Beauty serves as a bridge between luxury beauty and the natural world, ensuring that our customers experience the essence of " Be True in Life, Be Kind to Earth, Be a Beautiful You" while nurturing both their outer and inner beauty.​​About Langham PlaceLangham Place, under Champion REIT, is strategically situated in the bustling heart of Mong Kok, Kowloon. This iconic 15-story landmark serves as a premier destination for fashion enthusiasts. Boasting nearly 200 retail outlets, Langham Place offers a diverse array of international and local fashion brands, an eclectic mix of dining options, a state-of-the-art cinema, and the expansive beauty concept store, LANGHAM BEAUTY. The mall elevates the social and shopping experience by hosting a variety of cultural and creative promotional activities throughout the year. Notably, Langham Place is the first property in Hong Kong to achieve the EDGE (Excellence in Design for Greater Efficiencies) certification for existing buildings and has been honored with the Platinum rating by BEAM Plus, the highest accolade for existing buildings. Copyright 2024 ACN Newswire via SeaPRwire.com.

SF Holding successfully listed in Hong Kong

HONG KONG, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - As a pillar of global economy, the logistics industry represents a multi-trillion dollar market opportunity with enormous scope for imagination. Among all regions, Asia is one of the regions with the largest, fastest-growing and least concentrated logistics market. It has the most attractive growth prospects and has also given birth to the well-established logistics giant.On 27 November 2024, S.F. Holding Co., Ltd.  (6936. HK), the leader in the Asian logistics industry, went public in Hong Kong. According to the company's announcement, the offer price of SF Holding has been set at HK$34.30 per H-share, raising a total of HK$5.83 billion. Through this IPO, the Company aims to further promote internationalization strategy, establish overseas equity financing platforms, optimize international brand image, and enhance comprehensive competitiveness.High-quality service builds brand powerOver the past decade, with the “1-to-n” expansion strategy, SF Holding has quickly transformed from China’s leading time-definite express delivery service provider into a leading global integrated logistics service provider. The Company provides full-spectrum logistic services, including time-definite express delivery, economy express delivery, freight delivery services, cold chain logistics services, intra-city on-demand delivery services, supply chain services and international logistics services, and provides one-stop solutions to multinationals, large corporations, small and medium enterprises and retail customers.Leveraging its integrated capabilities, SF Holding provides full spectrum of services catering to the diverse logistics needs of customers across industry verticals, and becomes the go-to brand of customers for differentiated and premium services. In terms of fresh and seasonal food, the Company is the undisputed leader in China, providing doorstep delivery of live Yangcheng Lake hairy crabs, lichee, mango, and more to customers all over China. In terms of pharmaceuticals, it is among the very few logistics players globally to offer one-stop and highly reliable vaccine transportation solutions. In terms of luxury, it is the first to provide luxury time-definite express “SF Shangpai”, a delivery service with couriers dressed in tailored suits and trained in brand storytelling.As a testament to its leadership in time-definite express and exceptional services, SF Holding has been ranked first in overall customer satisfaction for 15 consecutive years (2009 to 2023). It has been enlisted among Fortune’s Global Top 500 companies for three consecutive years, distinguishing itself as the only private Chinese logistic enterprise on the list, securing the 415th position in 2024.Sustainable development of business is driven by technologyFor modern logistics enterprises, technological progress may significantly optimize warehouse management, improve delivery accuracy, and enhance customer experience, bringing about a dual improvement in economic and social benefits. Under the concept of technology driven, SF Holding utilizes proprietary technology and innovation to digitize internal management, improve operational efficiency, and accelerate business expansion.At present, SF Holding has embedded technologies in every aspect of its operations. It employs a data-driven approach to empower its first-mile pickup to last-mile delivery services. At the same time, it has adopted a digitalized dispatch scheduling and management system that optimizes efficiency for its land, air, and multimodal transportation. To enhance financial performance management, the Company has developed an advanced data modeling and analytical system. This system aids business teams in pinpointing potential areas for cost-reduction, facilitating efficient operational management and decision making.SF Holding has been widely recognized for its achievements in technological innovations. It was on Fortune Magazine’s Most Influential IoT Innovation List in 2022 and 2023. As of 30 June 2024, it had 4,199 patents and patent applications, being ranked the first among the global top four integrated logistics service providers, and 2,535 software copyrights in the fields of automation, big data and smart hardware, among others, according to Frost & Sullivan.SF has achieved significant scale, growth, and profitability, and is now at an inflection point for high-quality and sustainable growth. In the first three quarters of 2024, the Company achieved a revenue of RMB206.9 billion, representing a year-on-year increase of 9.4%, and net profit attributable to owners of the Company of RMB7.6 billion, representing a year-on-year increase of 21.6%. Upon successful “A-to-H” listing, the Company is believed to have a more stable and solid path of long-term endogenous growth in the future. Copyright 2024 ACN Newswire via SeaPRwire.com.

Expert Systems Announces FY25 Interim Results

HONG KONG, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - Expert Systems Holdings Limited (“Expert Systems” or the “Group”; Stock Code: 8319), a leading technology and innovation company in the Asia-Pacific region, today announced the unaudited interim results of the Company and its subsidiaries (the “Group”) for the six months ended 30 September 2024 (the “Reporting Period”). During the Reporting Period, the Group actively responded to market challenges and achieved an increase in gross profit margin despite the downward adjustment in business volume, demonstrating its strong business resilience.During the Reporting Period, the Group recorded revenue of approximately HK$437.2 million. Gross profit amounted to HK$70.9 million, and profit for the 1HFY2025 was HK$7.1 million. The market environment remained uncertain due to factors such as the global economic slowdown and the ongoing Sino-US competition. Nevertheless, the Group actively addressed the market challenges by optimizing its product mix and implementing effective cost-management measures. As a result, its gross profit margin increased from 14.6% in the same period last year to 16.2% during the Reporting Period, underscoring its unwavering business resilience.Mr. Andy Lau, CEO and Executive Director of Expert Systems, said: "Recognizing that the macro environment has been impacted by numerous uncertainties, we have not only made efforts to address challenges, but also adjusted our strategies and optimized our costs. In operating our product lines, we have focused our resources on businesses with high growth potential, including cybersecurity, automation, artificial intelligence (AI) and managed services. Through the close cooperation between our subsidiaries, we have been able to realize their respective advantages and provide comprehensive, one-stop solutions to meet the diverse needs of customers. This horizontal development has helped us to integrate the strengths of various business segments, which has not only enabled us to provide customers with high-value-added integrated solutions, but also enhanced our competitive advantage and laid a solid foundation for our business growth. While optimizing our product portfolio, we have also maintained effective capital allocation, focused on profit margin improvement, and actively responded to the changing business environment."BUSINESS REVIEWIT Infrastructure SolutionsThe Group has continued to provide world-class IT infrastructure solutions to corporate and institutional customers to meet their needs. In light of the frequent occurrence of cybersecurity incidents in recent years, the Group is committed to deploying appropriate cybersecurity solutions to safeguard its customers’ valuable IT assets. Additionally, in response to customers’ strong demand for automation, the Group also provides a wide range of IT infrastructure solutions that align with market trends and the surging demand. Among them, AI can comprehensively assist customers with business automation. To this end, the Group has developed a series of Generative AI (“GenAI”) applications and now offers a one-stop service that encompasses everything from infrastructure to GenAI applications, thereby eliminating any deployment and maintenance support concerns for customers. At this stage, the Group will prioritize allocating resources to two business growth engines of cybersecurity and automation (including AI). This focus aims to enhance its product portfolio and technical support, committed to providing customers with more valuable and comprehensive solutions, thereby driving business growth.IT Infrastructure Management ServicesThe Group anticipates growth in demand for IT infrastructure management services throughout the Asia-Pacific region. The Group’s service desk centers in Guangzhou and Kuala Lumpur provide IT outsourcing, help desk and other services to corporate and institutional customers, supporting over 60,000 incidents each month in seven languages. To address new demand, the Group plans to relocate the Guangzhou service desk center to a new facility and expand its capacity. Furthermore, the Group aims to extend its offerings to managed professional services (MPS), including a Network Operation Center (NOC) and Security Operation Center (SOC). All the above are expected to be completed by the first half of 2025. The service desk centers in both locations will create synergies, effectively balancing resources across regions and providing flexible services to customers, which further enhance the Group’s ability to meet the diverse customer needs. In addition, in response to the rising number of cybersecurity incidents, the Group has increased its resources to provide comprehensive cybersecurity consulting services, aiming to help customers proactively prevent cybersecurity incidents.AI BusinessThe Group continues to boost its GenAI business and has successfully developed a series of GenAI products based on cloud or on-premises large language models (“LLM”) for its corporate and institutional customers. The GenAI product series, namely ChatSeries, which includes ChatEnquiry, ChatMinutes and ChatSerivceDesk, offering a variety of functionalities to meet customer needs. Benefiting from the accelerated development of the AI ecosystem in Hong Kong, the Group has received a significant number of inquiries from clients, indicating the strong market demand. This sector is expected to be one of the key drivers in new business growth for the Group.Mr. Lau concluded: "As we enter 2025, Expert Systems will celebrate its 40th anniversary. The two core businesses of IT infrastructure solutions and IT infrastructure management services, as the cornerstones of Expert Systems, provide us with a solid foundation in a volatile market environment, while allowing us to actively develop new AI businesses. Looking ahead, Expert Systems will continue to focus on implementing strategic initiatives, including optimizing product portfolio and cost management, and continue to invest in technological research and development. We will actively respond to market challenges, strive to create value for shareholders and stakeholders, and drive the company to achieve sustainable growth."About Expert Systems Holdings Limited (Stock code: 8319)Established since 1985, Expert Systems Holdings Limited (“ESHL”) is a leading technology and innovation company which operates under the brands “Expert Systems”, “ServiceOne” and “Expert AI Enabling” with around 1,000 IT professionals. We are principally engaged in the provision of IT infrastructure solutions, IT infrastructure management services, and in the development and provision of AI products and AI solutions for corporate and institutional customers in the Asia-Pacific region. For more information, please refer to ESHL's website: https://www.expertsystems.com.hk/.Media Enquiries:Strategic Financial Relations LimitedHeidi SoTel: (852) 2864 4826Email: heidi.so@sprg.com.hkRachel KoTel: (852) 2114 2370Email: rachel.ko@sprg.com.hkMaggie KoTel: (852) 2864 4890Email: maggie.ko@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.

SCIB Reports 14.6% Revenue Growth to RM45.1 Million in Q1FY2025

KUCHING, MALAYSIA, Nov 28, 2024 - (ACN Newswire via SeaPRwire.com) - Industrialised building systems specialist, Sarawak Consolidated Industries Berhad ("SCIB" or the "Company") is pleased to announce its unaudited financial results for the first quarter of the fiscal year 2025 (“Q1 FY2025”). The Company reported a revenue of RM45.1 million, marking a 14.6% year-on-year increase compared to RM39.4 million in Q1 FY2024. The growth in revenue is largely due to the increased recognition of construction works done from ongoing projects.Ku Chong Hong, Managing Director of SCIBAs for Q1FY2025, SCIB's Manufacturing division continues to play a pivotal role in the Company’s performance, contributing RM32.5 million to the total revenue, a 9.80% increase from RM29.6 million in Q1 FY2024. This growth was primarily driven by increased sales of foundation piles and Industrialised Building System (“IBS”) products, especially for major projects such as the Kuching Urban Transportation System (“KUTS”), the Sarawak Second Trunk Road (“STR”) and school projects in Sarawak.Profit Before Tax (“PBT”) for the manufacturing segment stood at RM3.8 million. Meanwhile, the Construction/Engineering, Procurement, Construction and Commissioning (“EPCC”) division reported revenue of RM12.6 million, an increase from RM9.8 million in the same quarter last year. However, the segment recorded a Loss Before Tax (“LBT”) of RM2.0 million due to unanticipated unrealised foreign exchange loss recognised. The division remains focused on delivering ongoing projects while exploring new opportunities for expansion.During the quarter, SCIB maintained its commitment to strengthening its financial foundation and broadening its project portfolio. The Company has secured a contract worth RM162.0 million for development and infrastructure works under the Program Perumahan Penjawat Awam (“PPAM”) in Mualim, Perak. Additionally, SCIB had recently acquired a 2.49-hectares land parcel at Bintulu Sibiu Road, Bintulu, for RM9.2 million, followed by another parcel of 7.3-hectares land in Jalan Bintulu-Sibu as part of its plan to collaborate with developers for residential housing projects that utilise SCIB’s high-quality products and industry expertise, while expanding SCIB’s products and services offering to serve the fundamental needs of the Sarawak market.Mr. Ku Chong Hong, Managing Director of SCIB, commented, “The results of Q1 FY2025 reflect the challenges of a dynamic economic environment. However, we remain steadfast in our commitment to strengthening the financial foundation of the Company. Besides targeting to secure projects consistently, the recent securing of financial facilities from SME Bank and the proposed private placement of 10.0% of SCIB’s total issued shares underscore our focus on enhancing our cash position and ensuring financial stability to support our operational and strategic initiatives."Looking ahead, SCIB remains optimistic about Malaysia’s construction sector, bolstered by the record allocation in Budget 2025 of RM421 billion, including RM86 billion for development expenditure. The RM5.9 billion allocated for Sarawak, aimed at upgrading public infrastructure such as schools, healthcare centres, and airports, as well as large-scale projects like the Sabah-Sarawak Link Road (“SSLR”) and the North Coastal Highway, aligns seamlessly with SCIB’s expertise and strategic direction. The Company is poised to leverage its manufacturing capabilities and strategic initiatives to secure a strong foothold in both local and regional markets, ensuring sustainable growth and long-term value for its stakeholders.ABOUT SARAWAK CONSOLIDATED INDUSTRIES BERHADSarawak Consolidated Industries Berhad (“SCIB”) was founded in 1975 and has evolved from a small enterprise into a reputable Group of companies listed on the Main Market of Bursa Malaysia Securities Berhad. Currently, SCIB is operating three factories in Kuching, Sarawak, one factory in the Pending Industrial Estate and two factories in the Demak Laut industrial park.SCIB is well known for professional management and has long history of innovative ideas and technological advances. Coupled with its wealth of experience and research acquired in more than three decades, SCIB offers its clients in-depth expertise through a combination of technology, efficiency and speed.For more information, visit scib.com.my.Issued By: Swan Consultancy Sdn. Bhd. on behalf of Sarawak Consolidated Industries BerhadFor more information, please contact:Jazzmin WanEmail: j.wan@swanconsultancy.bizStephanie ChowEmail: s.chow@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.

Cropmate Berhad IPO Oversubscribed by 84.88 Times

KUALA LUMPUR, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - Cropmate Berhad (“Cropmate” or the “Company”), a key player in the conventional and specialty fertiliser manufacturing industry in Malaysia, is pleased to announce that its Initial Public Offering (IPO) for the Malaysian public has been oversubscribed by 84.88 times, indicating strong investor interest in Cropmate’s growth trajectory and prospects.Managing Director of Cropmate Berhad, Mr. Lee Chin YokCropmate’s IPO of 260.00 million ordinary shares (“IPO Shares”) consists of a Public Issue of 210.00 million new ordinary shares (“Issue Shares”) and an Offer for Sale of 50.00 million shares (“Offer Shares”) involving:(I) Institutional offering of 208.34 million IPO Shares in the following manner:158.34 million Issue Shares allocated via private placement to institutional and selected investors, including 42.25 million Issue Shares approved for Bumiputera investors by the Ministry of Investment, Trade and Industry (“MITI”); and50.00 million Offer Shares allocated via private placement for Bumiputera investors by the MITI.(II) Retail offering of 51.66 million IPO Shares in the following manner:36.90 million Issue Shares made available for application by the Malaysian public via balloting, with an equal allocation between Bumiputera and non-Bumiputera investors; and14.76 million Issue Shares reserved for application by the eligible directors of the Company, employees of Cropmate and its subsidiary (“Group”) and persons who have contributed to the success of the Group (“Eligible Persons”).The Group received a total of 21,392 applications for 3,169,052,100 Issue Shares with a value of approximately RM633.81 million were received from the Malaysian public, which represents an overall oversubscription rate of 84.88 times. For the Bumiputera portion, a total of 10,745 applications for 1,368,843,700 Issue Shares were received, which represents an oversubscription rate of 73.19 times. For the public portion, a total of 10,647 applications for 1,800,208,400 Issue Shares were received, which represents an oversubscription rate of 96.57 times.The 14.76 million Issue Shares made available for application by the Eligible Persons were fully subscribed.Under the Institutional Offering of 208.34 million of IPO Shares, the Bookrunner has confirmed that it has received interests to subscribe the 158.34 million Issue Shares allocated via private placement to institutional and selected investors, including 42.25 million Issue Shares for Bumiputera investors by the MITI, as well as 50.00 million Offer Shares allocated via private placement for Bumiputera investors by the MITI.Managing Director of Cropmate Berhad, Mr. Lee Chin Yok, expressed, “The robust response to our IPO reflects the trust that investors have placed in Cropmate’s business and strategic direction. We are grateful for this overwhelming support and excited to move forward with our plans to enhance our operations and customer service capability to meet the growing demand for our fertilisers.”Mr Lee also added, “The enthusiastic response from investors underscores their belief in Cropmate’s future potential. This support motivates us to strengthen our operations and continue innovating to meet the evolving needs of the agriculture industry.”Group Managing Director/Chief Executive Officer of Hong Leong Investment Bank Berhad (“HLIB”), Ms. Lee Jim Leng, remarked, “The strong demand for Cropmate’s IPO is a testament to the investment community’s recognition of the Company’s solid management team and their prospects. Cropmate is well-positioned to make a meaningful impact in the agricultural sector, and we are honoured to support them in their journey.”Hong Leong Investment Bank Berhad is the Principal Adviser, Sponsor, Underwriter and Bookrunner.Cropmate Berhad is scheduled to make its debut on the ACE Market of Bursa Securities on 5 December 2024.About Cropmate Berhad (“Cropmate”)Founded in 2018, Cropmate Berhad is an established fertiliser manufacturer and supplier in Malaysia, specialising in the formulation and blending of conventional and specialty fertilisers. With a focus on innovation and sustainability, Cropmate offers a wide range of products designed to enhance agricultural productivity, including compacted and blended fertilisers, as well as semi-organic, organic, and liquid fertilisers. Led by industry veterans with decades of experience, Cropmate is committed to supporting farmers in improving crop yield and quality. As the first pure-play fertiliser company listed on Bursa Malaysia, Cropmate continues to advance its mission of contributing to the growth and sustainability of the agricultural sector.For more information, visit https://www.cropmate.com.my/Issued By: Swan Consultancy Sdn. Bhd. on behalf of Cropmate BerhadFor more information, please contact:Jazzmin WanEmail: j.wan@swanconsultancy.bizWilliam YeoEmail: w.yeo@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.

Survey: New Opportunities in Cross-border E-commerce

HONG KONG, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Export Credit Insurance Corporation (HKECIC) and Hong Kong Trade Development Council (HKTDC) jointly released a research study today, titled "Unleashing the Lucrative Potential of Cross-border E-commerce for Hong Kong Traders". The study revealed that 90% of surveyed companies anticipated that cross-border e-commerce could drive significant sales growth in the business in the next two years.  However, the market-related challenges continue to persist, including intense market competition, complex customs clearance procedures and the management of returns and refunds. In light of these challenges, experts recommend developing appropriate online marketing and sales strategies, enhancing risk management and adopting efficient logistics and delivery practices to better seize the opportunities presented by cross-border e-commerce.Mr Terence Chiu, Commissioner of HKECIC, said, “The joint research study of the HKECIC and the HKTDC helps the industry in gaining deeper understanding of the latest development in expanding cross-border e-commerce, as well as outlining the challenges faced by businesses and the support they needed. While cross-border e-commerce has seen a significant growth in recent years, the study highlighted that the market remains highly competitive, and the ecosystem and related infrastructure still require further improvement.  In addition, many e-commerce businesses have limited assets and insufficient collateral to secure financing from traditional banks and financial institutions, reflecting the ongoing challenges in the e-commerce environment. This year, the HKECIC has collaborated with a fintech and a reinsurance company, and also a bank to develop bespoke trade credit insurance solutions, aiming to provide coverage for trade loans to Hong Kong e-commerce businesses. These initiatives encourage and support local enterprises in securing trade financing and expanding into cross-border e-commerce. The HKECIC will actively seek collaboration with more financial institutions, in line with the 2024 Policy Address, to better support Hong Kong businesses in securing e-commerce export financing. By leveraging its expertise in trade credit insurance and risk management, the HKECIC is dedicated to assisting Hong Kong businesses in maintaining their competitive edge, helping them explore new overseas markets, mitigate trade risks and reduce operating costs.”Dr Patrick Lau, HKTDC Deputy Executive Director, said, “E-commerce has become a key driver of the global economy. The World Bank estimates that global B2C e-commerce sales will reach US$6 trillion by 2024, with Mainland China leading the way – over a quarter of retail consumer goods sales occur online. In collaboration with the HKECIC, the study aims to help Hong Kong businesses explore new markets and seize opportunities. The HKTDC will continue to support local companies in engaging with e-commerce and taking advantage of growth opportunities on the global stage.”From June to August 2024, the HKECIC and the HKTDC conducted phone and online interviews with 352 local trade and manufacturing companies to assess the development of Hong Kong companies’ cross-border e-commerce operations, while also detailing the challenges they face and identifying the support services they require.Driving significant sales growth in the next two yearsAs network technology has become more widespread, while electronic payment services are now ubiquitous and e-commerce platforms have come to offer an ever-expanding range of services, even new entrants and smaller businesses can easily develop cross-border e-commerce operations on a global basis. 90.0% of surveyed companies anticipated that cross-border e-commerce could raise their total sales revenue in the next two years.The surveyed companies in general indicated that cross-border e-commerce positively impacts their expansion plans whether via broader sales channels (69.0%), new market opportunities (50.3%), or enhanced brand awareness (48.9%).Reaching out to global markets: Focusing on the Mainland and ASEANHKTDC Principal Economist Wing Chu, who led the study, said, “The scope of cross-border e-commerce business for Hong Kong companies spans all parts of the world, covering markets, such as Mainland China (75.2%), ASEAN (53.0%), the US (42.2%), Japan (30.9%) and the EU (30.0%). Looking ahead, respondents generally agreed that, for the next two years, Mainland China (61.6%) and ASEAN (44.3%) offer the greatest growth potential. The surveyed companies generally hope to make use of risk management to meet market competitiveness and the challenges outlined, such as insurance for cargo transportation or payments (39.8%), e-commerce promotion (34.4%) and logistics services for both delivery and product returns (33.5%).”Coping with online and offline challengesCross-border e-commerce operators must confront a variety of practical issues relating to both online and offline procedures, including goods delivery, platform charges, exchange rates and refunds as well as market, regulation and financing issues.Of the companies surveyed, 38.4% said that customs clearance procedures in Mainland China and foreign markets are complex, with 31.3% indicating that product returns involve complicated procedures and / high costs, and 29.8% finding it difficult to manage practical issues, such as the international delivery of small orders.Regarding the issues of platform charges, exchange rates and refunds, the high commission rates charged by third-party e-commerce platforms and long payment periods were identified as challenges by 51.1% of respondents. Meanwhile, 46.6% said fluctuating exchange rates or high exchange costs were problems they faced during their cross-border e-commerce operations. 28.4% were concerned about the expansive costs about refund policy.In addition, companies must contend with a wide range of difficulties. Majority of the surveyed companies (84.9%) noted that developing cross-border e-commerce presented market-related challenges, such as keen market competition. Meanwhile, 54% indicated regulatory issues, and 41.2% encountered financial challenges.Leveraging Hong Kong's advantages to unlock global e-commerce opportunitiesIn addition to the questionnaire, HKTDC also interviewed a number of companies engaged in cross-border e-commerce or related businesses. According to expert’s opinion, though the mainland market is huge in scale, the competition is keen. Overseas opportunities abound, such as the advanced economies of Europe and America have mature online shopping markets and e-commerce markets in Southeast Asia.In addition, online sales strategies tailored to target markets are of prime importance, including the collaboration with KOL or influencers and using short-form videos to attract consumers.The study also highlighted Hong Kong's excellent logistics capabilities and extensive air cargo network as well as its well-developed financial markets and diverse financing services, which are well-suited to meeting the financial needs of e-commerce. Meanwhile, Hong Kong serves as an ideal gateway for foreign products entering Mainland China, with the Hong Kong brand enjoying a competitive edge in the region.Photo download: https://bit.ly/3Bb95BADr Patrick Lau, Deputy Executive Director, HKTDC (left) and Terence Chiu, Commissioner, HKECIC (right)Dr Patrick Lau, Deputy Executive Director, HKTDC (second left); Terence Chiu, Commissioner, HKECIC (second right); Wing Chu, Principal Economist, HKTDC (first left); and Cynthia Chin, General Manager, HKECIC (first right)References- HKTDC Research Portal https://research.hktdc.com/en- Unleashing the Lucrative Potential of Cross-border E-commerce for Hong Kong Traders https://research.hktdc.com/en/article/MTg1OTQ2Mzk3MwAbout HKECICThe HKECIC was established in 1966 under the Hong Kong Export Credit Insurance Corporation Ordinance (Chapter 1115).  Through the provision of export credit insurance services, the HKECIC protects Hong Kong exporters who trade on credit terms with overseas buyers against non-payment risks and helps them conduct export business in a prudent manner.  The HKSAR Government provides a guarantee of HK$80 billion for HKECIC’s contingent liability.About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedInMedia enquiriesHKECICCorporate Communication DivisionTina NgTel: (852) 2732 9998Email: tina.ng@hkecic.comHKTDCCorporate Communication & Marketing DepartmentSharon HaTel: (852) 2584 4575Email:sharon.mt.ha@hktdc.orgYuan Tung Financial Relations LimitedLouise SongTel: (852) 3248 5691Email: lsong@yuantung.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.

Kingworld-Longde Life and Health Industrial Park Grand Opening

HONG KONG, Nov 27, 2024 - (ACN Newswire via SeaPRwire.com) - Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced that the Group's Kingworld • Longde Life and Health Industrial Park ("Longde Health Industrial Park" or "Industrial Park") in Bao’an Technology City, Longgang District, Shenzhen, has officially commenced operations. The opening ceremony, investment promotion conference, and investor tour were successfully held, marking a new chapter in the Group's 30-year journey in the healthcare industry and establishing a national-level pharmaceutical industry incubation and investment base for the Greater Bay Area. On the same day, Kingworld and Foci jointly launched their new product "Foci Kingworld An Gong Niu Huang Wan."Zhao Li Sheng, Chairman of Kingworld Medicines,attended the grand opening ceremony of Kingworld • Longde Life and Health Industrial Park.The Longde Health Industrial Park was developed according to the national health industry development strategy and aligned with Shenzhen and Longgang District's industrial development plans. Located at the strategic intersection of Shenzhen's Eastern High-speed Rail New Town and International Low-Carbon City, the park covers 10,000 square meters with a total construction area of 57,000 square meters. The park features high-standard production facilities and supporting infrastructure, including pharmaceutical waste treatment facilities, backup power supply systems, and centralized pharmaceutical wastewater treatment systems, providing comprehensive support for the diverse needs of resident enterprises.Construction of Kingworld • Longde Life and Health Industrial Park began in December 2020,planned as a comprehensive park integrating R&D,production, and office facilities for traditional Chinese medicine, Hong Kong medicine, and other health industry enterprises.As a key strategic project of Kingworld Medicines, the Longde Health Industrial Park leverages Kingworld's 30-year global pharmaceutical supply chain resources, mature sales network, and marketing capabilities. It actively integrates pharmaceutical supply chain resources to help park enterprises effectively expand their market channels and provides targeted professional support in financing, listing, policy, and legal matters to accelerate the incubation of pharmaceutical projects and brands aligned with the Group's strategic direction. The Industrial Park has also established innovation platforms, including a Greater Bay Area Youth Exchange Base and Hong Kong Medicine Landing Platform.Furthermore, the Industrial Park houses high-end research institutions including “Hong Kong Medicine Landing Hub”, “Shenzhen-Hong Kong TCM In-Hospital Preparatory Medicinal Products Center” and “Pharmaceutical GSP Supply Chain Distribution Center”. The park has created a life and health achievement transformation platform integrating research institutions, Shenzhen-Hong Kong medical institutions, research experts, and pharmaceutical distribution, making positive contributions to the innovative development of the biomedical industry in the Greater Bay Area.Mr. Zhao Li Sheng, Chairman of Kingworld Medicines, stated: "The Longde Health Industrial Park, as a strategic project in Kingworld Group's Fifth Five-Year Plan, represents a significant milestone in the Group's development. Kingworld Medicines consistently prioritizes technological innovation, emphasizes ecological environmental protection and sustainable development, and strives to create synergistic innovation effects. We aim to build a modern, intelligent, and green health industrial park integrating R&D, production, logistics, and sales, effectively consolidating and maximizing the Group's health industry resources. We hope to establish the park as Longgang's new landmark in the pharmaceutical industry, creating a new highland for exploring health technology, nurturing health industries, and serving human health, contributing to the prosperous development of the pharmaceutical and healthcare industry in Longgang and the Greater Bay Area."Zhao Jian Wei (first from right),Managing Director of Kingworld-LongdeHealth,signed a strategic cooperation agreement with partners includingShenzhen Angel FOF and Elong Hotel Technology (under Tongcheng Travel).Simultaneously,they also signed an agreement with Xingwu (Shenzhen) TechnologyCo., Ltd.,which represents one of the enterprises entering the industrial park.About Kingworld Medicines Group ( Stock code: 01110.HK )Kingworld Medicines Group (stock code: 01110.HK) has been committed to building a comprehensive upstream and downstream supply chain system in the healthcare industry for over thirty years, with business coverage in more than 34 provinces and cities across China. In order to adapt to the new trend of consumer upgrading, Kingworld Medicines has built a new retail ecosystem both online and offline. Shenzhen Kingworld Medicines a subsidiary of the Group, mainly engages in the agency of imported branded pharmaceutical and healthcare products in China, and has established a reputation as a leading agent for well-known brands such as Nin Jiom Pei Pa Koa, Taiko Seriogan, Kingworld Imada Red Flower Oil and Foci Kingworld An Gong Niu Huang Wan. For more information, please visit https://www.kingworld.com.cn/If you have any media enquiries, please contact LBS Communications Consulting LimitedMs Joanne ChanTel:(852) 3679 3671Email:jchan@lbs-comm.com Mr Jason HoTel:(852) 3752 2675Email:jho@lbs-comm.com Email:kingworldir@lbs-comm.com  Copyright 2024 ACN Newswire via SeaPRwire.com.